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Abstract 
Substance use disorders cause significant neurological damage, cognitive impairment, 
and maladaptive behaviors that negatively affect a person’s quality of life. The purpose of 
this study was to explore the effect gender and primary drugs have on locus of control. 
Generalized expectancy theory helped to explain the behavior of patients diagnosed with 
substance use disorders and their inability to control ongoing drug use. The research 
question focused on to what extent drug-related locus of control scores differ by primary 
drug (narcotic vs. stimulant), gender (male vs. female), and their interaction. Data 
measuring locus of control from 553 participants provided a subset of 410 participants 
who identified narcotics or stimulants as their primary drug. A 2x2 full factorial ANOVA 
was conducted. The results of this study indicated there is a significant interaction 
between primary drug use and gender. The results could have positive social change 
implications for the addiction field because of the value of understanding the 
interdependency of internal-external thought processes related to drug use, the ability to 
change stigma associated with addiction and gender, and the value of understanding the 
need for individualized treatment as locus of control shifts from external to internal. It is 
recommended that the drug-related locus of control instrument become part of treatment 
protocol along with evidence-based interventions. 
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Chapter 1: Introduction to the Study 
The Substance Abuse and Mental Health Services Administration (SAMHSA, 
2015) reported the use of opioids, hallucinogens, stimulants, cannabis, tobacco, and 
alcohol causes significant cognitive, behavioral, and social impairments, and negatively 
affects a person’s quality of life. Physiological and psychological dependence on foreign 
chemicals not naturally produced in the body was the previous definition of substance 
abuse. In the updated edition of the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-V), terminologies such as substance abuse or dependence 
were replaced with substance use (American Psychiatric Association [APA], 2013). 
Disruptions in family structure and harmony, legal or health issues, and adverse influence 
on employment advancements or educational achievements are elements that were 
identified and diagnosed as an addiction due to substance abuse or dependence (Bao et 
al., 2009; Caan, 2012; Gifford & Humphreys, 2007; Grant, Potenza, Weinstein, & 
Gorelick, 2010). Now, according to DSM-V, functionality associated with substance use 
is the major focus of a substance abuse disorder diagnosis, along with the degree of 
impairment. According to Cann (2012) and Kreek, Nielsen, Butelman, & LaForge 
(2005), substance use disorders affect not only the individual’s quality of life, but that of 
other citizens on a local, state, and national level. Social service providers have 
responded to increased needs for shelter and food, along with physical and mental health 
services based on the inability of individuals with a substance use disorder to sustain 
themselves in the community without additional resources. Medical professionals have 
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been confronted with reduced resources based on drug related treatment issues that 
included injuries, overdoses, and diseases such as Human Immunodeficiency Virus and 
Acquired Immunodeficiency Syndrome. The overuse of various substances also 
contributed to emotional, mental, and psychological impairments such as psychosis, 
depression, and anxiety, which drained scarce resources of mental health providers. 
Substance users pushed the capacity of the criminal justice system as facilities tried to 
accommodate drug-related criminals. Most important, the United States suffered from the 
loss of productive workers, as substance users lack the capacity to perform in 
employment and educational settings.  
 The multiple repercussions associated with substance abuse left the public with 
negative opinions about people with a substance use disorder. The stigma attached to 
those suffering from substance use disorders contributed to the development of a social 
movement. The movement included the need to shift public opinion away from negative 
association related to addiction. Davidson et al. (2008) argued the omission of the word 
addict from the treatment process would help shift thought processes toward positive 
interventions such as patient empowerment and patient-centered care. Karim and 
Chaudhri (2012) and McLachlan and Starkey (2012) suggested redefining the traditional 
view of people with addiction and providing the most appropriate treatment such as an 
individualized assessment tool. The Drug-Related Locus of Control (DRLOC) scale is an 
individualized assessment tool that targets the patient’s needs and supports the 
implementation of patient-centered care (Hall, 2001). By understanding the score 
3 
 
generated by the DRLOC scale, patients could recognize their addictive thought 
processes in order to control their behavior, thereby minimizing the negative effect 
addiction has on medical, mental health, legal and family systems, and the stigma 
associated with substance use disorders. 
Despite Davidson et al.’s (2008), Karim’s and Chaudhir’s (2012), and 
McLachlan’s and Starkey’s (2012) efforts to change the negative opinions and social 
stigma related to people diagnosed with substance use disorders, drug addiction 
continued to plague the United States and other countries throughout the world and have 
reached an epidemic level (Baird, 2015; Rollins, 2016; Worley, Heinzerling, Shoptaw, & 
Ling, 2015). The United Nations Office on Drugs and Crime (UNODC, 2015a), 
documented an estimated 162 to 324 million people, globally, reported the use of some 
form of illicit drugs. Mennis, Stahler, and Baron (2012) reported 205 million people 
worldwide abused drugs during 2012. In the United States, the prevalence of addiction 
continued to negatively affect the country with 23.9 million Americans who reported the 
use of illegal drugs between 2008 to 2012 (Cummins, Nadorff, & Kelly, 2009; 
SAMHSA, 2013a).  
In California, each year from 2010 to 2014, approximately 876,000 residents 
reported the use or abuse of illicit drugs (SAMHSA, 2015). SAMHSA (2013a) reported 
947,000 people in California abused illicit drugs in 2012. However, less than 115,000 of 
the 947,000 people received some form of treatment. The following year, California 
reported 169,875 admissions into various treatment programs with 136,654 initial 
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admissions and 33,221 readmissions, indicating individuals often sought treatment 
multiple times (California Department of Alcohol and Drugs Program [CDADP], 2013). 
The CDADP (2013) also found Methamphetamine was the most commonly reported 
primary drug of choice in the state, at a rate 13% higher than heroin.  
Substance use disorders involve complex neurological changes. They cause 
neurobiological reactions at a cellular level where molecules create structural changes 
and shifts in behavior . Genetics and environmental factors contribute to maladaptive 
behaviors and impaired thought processes, from the begin stage of drug use, to the 
escalation of drug abuse, and then finally addiction (CDADP, 2013; Kreek et al., 2005; 
SAMHSA, 2013a; UNODC, 2015a). The issues involved with substance use disorders 
warrant the need for ongoing studies from multiple disciplines, including research in the 
areas of social science, neuroscience, behavioral science, and cognitive science.  
The development and use of assessment instruments helped to identify and treat 
addictive behaviors (Ersche, Turton, Croudace, & Stochl, 2012; Hall, 2001; Neto & True, 
2011). Administering assessment instruments directly related to substance abuse and 
assisted clinicians in determining a patient’s readiness toward recovery, which helped 
guide the practitioner to implement one or multiple evidence-based treatment 
interventions. Treatment programs that administer the DRLOC assessment instrument 
during admission, while in treatment, and toward the end of services could be beneficial 
for measuring treatment success. 
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In Chapter 1, I provide the background of this study, along with an introduction to 
the development of the DRLOC scale and the original Internal-External Locus of Control 
(I-E LOC) instrument. Additionally, I identify the purpose and social significance of 
conducting the study, along with the methodology, hypotheses, and research questions. I 
also offer details concerning generalized expectancy theory, which I used for my 
theoretical foundation. Included in this chapter are the operational definitions of terms, 
along with the assumptions, limitations, and scope of the study. Finally, I provide the 
etiology of addiction and the significance and nature of the study, along with a deeper 
understanding of the social implications related to drug use. 
Background of the Study 
Addiction is a chronic relapsing disease (Davidson et al., 2008; Gifford & 
Humphreys, 2007; Grant et al., 2010; Vohs & Baumeister, 2009). There are two types of 
addiction: Chemical addictions related to foreign chemicals introduced into the body and 
behavioral or process addictions, developed from patterns of impulsive and compulsive 
behaviors (Buckland, 2008; Caan, 2012; Grant et al., 2010; Karim & Chaudhri, 2012; 
Shor & Levit, 2012). Both types of addictions share commonly identified 
biopsychosocial and behavioral features in the areas of development, maintenance, 
treatment, and recovery (Grant et al., 2010; Leeman & Potenza, 2013; McLachlan & 
Starkey, 2012). Addiction is a mental health disorder that presents with very complex 
behaviors and tends to cooccur with other mental health disorders (Caan, 2012; Carlson 
& Larkin, 2009; Congdon & Canli, 2008). 
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Over several decades, substance use increased (UNODC, 2015a; SAMHSA, 
2012). The UNODC monitored and annually reported drug activities from around the 
world. In 2012, 162 to 324 million people used illegal drugs (UNODC, 2015a). This 
number reflected the increased number of entries into treatment for substance use 
disorders over the past 10 years. California is one state where the availability of treatment 
continued to rise (CDADP, 2013).  
Ongoing drug use may be the result of personality traits influenced by impulsivity 
that caused addictive behaviors to develop (Caselles, Mico, & Amigo, 2010; Cyders et 
al., 2007; Whiteside & Lynam, 2001). People’s belief systems also influenced ongoing 
drug use and are directly related to their ability to obtain abstinence through treatment 
(Hall, 2001; Rotter, 1966).  
There are numerous commonalities across a wide range of substance use disorders 
that present with similar cognitive, neurological, and physiological symptoms. Substance 
use disorders also share similar behavioral characteristics in terms of etiology, 
functionality, and response to treatment interventions (Gifford & Humphreys, 2007; 
Grant et al., 2010). Individualized instruments that measure specific impulsive behaviors 
associated with seeking out and obtaining drugs and instruments that measure thought 
processes related to drug use are tools practitioners have used to help identify triggers 
(Cyders et al., 2007; Ersche et al., 2012; Hall, 2001; Whiteside & Lynam, 2001). I seek to 
understand whether the score generated from the DRLOC scale is influenced by gender 
and narcotic or stimulant (cocaine, crack, amphetamine, or Methamphetamine) abuse.  
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The stigma of seeing patients as addicts and not associating their addictions with a 
neurological disease resulted in the need to advocate for social change (Davidson et al., 
2008). Davidson et al. (2008) and Larkin, Wood, and Griffiths (2006) encouraged 
individuals and organizations in the healthcare field to demonstrate a positive shift in the 
words they chose to use and the way they treated patients with addictions. Davidson et al. 
(2008) further encouraged practitioners to become more person-centered.  
Person-centered regimens focus on patients as individuals, thereby providing 
customized treatment plans (Rogers, 1992). After the introduction of Rogers’ theory of 
patient-centered care, which allowed for individualized treatment plans and research 
approaches and consisted of six components, Kirschenbaum and Jourdan (2005) 
narrowed the six initial elements of patient-centered care down to three main 
components: Empathy, unconditional positive regard, and positive congruency. 
Incorporating patient-centered care across mental health and addiction settings could help 
diminish the stigma associated with substance use disorders (Kirschenbaum & Jourdan, 
2005). 
For this study, I examined chemical addictions, specifically those related to 
narcotic and stimulant (cocaine, crack, amphetamine, and Methamphetamine) abuse. The 
criterion related to these addictions and diagnoses are under the category of substance use 
disorders in the DSM-V. As noted by Caan (2012) and Congdon and Canli (2008), the 
development of addictive behaviors is complex. Rotter's generalized expectancy theory 
has been applied in the field of addiction to explain how past positive or negative 
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experiences determined whether people generalize their current experiences or reinforced 
them using internal or external beliefs, which placed value on similar experiences in the 
future. Rotter (1966) theorized that if people expected that similar situations or events 
would bring about a similar outcome, then impulsive people would respond according to 
the outcome they expected to occur. How much control people felt they had over similar 
outcomes determined how they responded (Rotter, 1966). Rotter and Mulry (1965) 
termed this belief system locus of control.  
Locus of control (LOC) has two constructs. The first construct described people 
who have an internal LOC. People with an internal LOC believe they had some control 
over the outcome of an event or situation regardless of the positive or negative result. If 
people believe they had limited or no control over an outcome, then Rotter and Mulry’s 
(1965) second construct labeled them with an external LOC. To measure these two 
constructs, Rotter and Mulry developed a unidimensional instrument called the Internal-
External LOC (I-E LOC) scale. The instrument was widely successful in different 
psychology and healthcare fields along with the field of employment. The effect 
generalized expectancy theory had on people’s LOC provided a theoretical foundation for 
examining thought processes associated with ongoing drug use.  
Since 1965, researchers adapted, modified, and translated the generalized I-E 
LOC scale for use in 43 countries and with those who speak different languages. 
Calicchia (1974) adapted the I-E LOC scale to measure LOC variations based on the use 
of narcotics. Keyson and Janda (1972) modified the I-E LOC scale to develop the 
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Drinking Related Internal-External (DRIE) LOC scale to measure LOC in alcoholics. 
Hall (2001) modified the DRIE instrument by changing the word alcohol to the word 
drug. Hall (2001) also changed other words associated with the use of alcohol to words 
associated with drug use to develop the DRLOC scale. The DRLOC instrument and all 
other LOC instruments developed before and afterward were based on Rotter and 
Mulry’s I-E LOC instrument.  
Hall (2001) and Ersche et al. (2012) administered the DRLOC instrument with 
500 plus participants that resulted in men’s LOC score being external. Hall (2001) 
questioned the results from studies with a small number of participants that documented 
most of the women produced an external score and studies with a large number of 
participants that demonstrated most of the men produced an external score.  
The current study adds to Hall’s research by examining gender, primary drug use, 
and their influence on DRLOC scores. The role of LOC and thought processes associated 
with drug use among men and women provided a conceptual foundation for the current 
study. Generalized expectancy theory provided a theoretical foundation for the current 
study and helped to understand why drug use continues. 
Problem Statement 
The UNODC (2015b) suggested opiates and opioids are the main culprits for most 
drug related deaths globally. In the United States, there was an increase in heroin usage 
from 15% in 2004 to 22% in 2014 and opiate abuse from 3% in 2004 to 8% in 2014 
(SAMHSA, 2016c). Methamphetamine abuse increased from 6% in 2004 to 9% in 2014 
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(SAMHSA, 2016c). Methamphetamine is the most commonly used illegal drug in 
California compared to heroin as a primary drug (CDADP, 2013). In California, there 
were 48,345 admissions into treatment for Methamphetamine and amphetamine abuse. 
Cocaine and crack cocaine accounted for 7375 admissions. Treatment for heroin abuse 
resulted in 38,785 admissions, while opiate abuse had 8,468 admissions (SAMHSA, 
2016d). 
 The focus of this study was to examine the effect gender and primary drug had on 
DRLOC. I was unable to locate recent research focused on LOC and narcotics, LOC and 
stimulants, or LOC with narcotic and stimulants.  
There were limited numbers of assessment tools used for measuring drug-related 
disorders and LOC. The original I-E LOC scale measured individuals’ belief in whether 
they could control their consumption of alcohol and did not focus on drug abuse (Rotter 
& Mulry, 1965). Calicchia (1974) used the I-E LOC scale to measure LOC and heroin 
usage. Hall (2001) developed the DRLOC scale to focus specifically on drug abuse 
among people in treatment programs. Ersche et al. (2012) studied the reliability of the 
DRLOC scale and reported the DRLOC scale to be an effective assessment tool for 
measuring LOC in people with substance use disorders. Their study measured LOC in a 
large sample of 592 participants with a history of alcohol and drug abuse. Past studies 
that used a generalized LOC instrument provided small sample sizes of less than 100 
participants and often less than 50 participants (Hall, 2001). I used Hall’s data generated 
from 553 participants to identify a subset of 402 participants; 117 identified narcotics as 
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their primary drug and 285 identified stimulants (cocaine, crack, amphetamine, or 
methamphetamine) as their primary drug. Once I identified the target sample, I examined 
their DRLOC scores to determine group mean differences by primary drug (narcotics vs. 
stimulants) and gender (male vs. female).  
Purpose of the Study 
The current study is a pre-experimental, quantitative study utilizing secondary 
data from a study conducted by Hall (2001) titled, Feelings About Drug Use, Drug-
Related Locus of Control, which, itself, was a follow-up to the University California Los 
Angeles’ (UCLAs) Integrated Substance Abuse Programs’ study titled, Drug Treatment 
Process and Drug Treatment Counselor Practices and Effectiveness study. The purpose of 
conducting this secondary analysis was to reexamine data regarding individuals who 
received treatment for their substance use disorders. Specifically, I examined the main 
factorial effects of primary drug (narcotic vs. stimulant), gender (men vs. women), and 
their interaction on DRLOC. In Chapter 2, I provide an in-depth discussion of the 
literature about the DRLOC instrument and its relationship to narcotic and stimulant 
disorders.  
Research Questions and Hypotheses 
The dependent variable is DRLOC, in which a low score indicated an internal 
LOC and a high score indicated an external LOC. Chapter 3 includes an in-depth 
description of the instrument. The independent variables are primary drug (narcotic or 
stimulant) and gender (male or female). Of primary interest was the effect of the primary 
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drug on DRLOC score, but because Hall (2001) found males had statistically significant 
higher DRLOC score than females, it was important to control for gender and examine 
any interaction effect between gender and primary drug. 
Coffey, Schumacher, Baschnagel, Hawk, and Holloman (2011) reported 
addictions contribute to maladaptive behaviors based on the lack of impulse control. The 
Drug Enforcement Administration (DEA, 2013), found a relationship between both 
narcotic and stimulant disorders and compulsive and impulsive behaviors. Bornovalova, 
Daughters, Hernandez, Richards, and Lejuez (2005) found people who used stimulants 
had a higher propensity for risky behavior and impulsivity than people who abused 
heroin. Furthermore, McAnena, Craissati, and Southgate (2016) suggested there is a high 
correlation between maladaptive behaviors, impulsivity, and external LOC. Although 
these findings suggested patients with substance use disorders who choose stimulants as 
their primary drug would produce an external LOC score based on impulsivity and a 
perceived lack of control over their maladaptive behaviors. All hypotheses for the 
proposed secondary analysis are nondirectional in order to afford an unbiased assessment 
of the data. To simplify the hypotheses that follow, the test of a specific effect assumes 
statistical control for the other effects. 
RQ1: To what extent do DRLOC scores differ by primary drug (narcotic vs. 
stimulant), gender (male vs. female), and their interaction? 
N01: There is no statistically significant difference (p > .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.  
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Na1: There is a statistically significant difference (p < .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.   
N02: There is no statistically significant difference (p > .05) in DRLOC scores 
between males and females.  
Na2: There is a statistically significant difference (p < .05) in DRLOC scores 
between males and females.  
N03: There is no statistically significant interaction effect (p > .05) between 
primary drug and gender on DRLOC scores.  
Na3: There is a statistically significant interaction effect (p < .05) between 
primary drug and gender on DRLOC scores. 
Theoretical Foundation 
Rotter (1966) introduced the generalized expectancy theory as a social learning 
theory addressing impulsive reactions supported by cognitive and behavioral responses to 
environmental stimuli. Generalized expectancy theory helped to explain the behavior of 
patients diagnosed with substance use disorders and their inability to control addictive 
behaviors associated with ongoing drug use. Rotter explained that the nature of impulse 
response is related to a current situation that is similar to prior experiences. Patients 
generalize the outcomes related to past drug-related experiences and used them to 
reinforce their behavior with similar drug-related experiences in the future, thereby 
establishing preconceived expectations. More details about generalized expectancy 
theory are provided in Chapter 2.  
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Addictive disorders involve behaviors related to impulsive and compulsive 
actions, including the inability to self-regulate or control behaviors (Sheffer et al., 2012; 
Webb, Sniehotta, & Michie, 2010). Due to the construct lack of control as related to 
substance use disorders, Rotter’s generalized expectancy theory provided a 
comprehensive explanation and the theoretical basis for understanding what drives 
ongoing addictive behaviors.  
Conceptual Framework 
Cognitive awareness of control is relevant to the assessment of ongoing substance 
use. Examining LOC was appropriate for measuring patients’ expectations regarding how 
much control they had or thought they had over their drug use based on prior experiences 
with drug-related activities (Sheffer et al., 2012; Webb et al., 2010). Internal LOC is 
defined as people’s ability to understand their role in a given situation and acceptance of 
the level of control they had in the outcome (Rotter & Mulry, 1965). People believing 
they had little control over a given outcome due to luck, faith, or another factor outside 
their control met the definition of external LOC (Rotter & Mulry, 1965).  
By applying the constructs of LOC, researchers could identify a person who 
believed he or she had a certain amount of control over their drug use compared to a 
person who believed there were other factors in the environment causing him or her to 
continue drug use. Examining LOC, coupled with generalized expectancy theory as 
applied to addiction, could help to identify patients’ expectations about what might occur 
due to prior positive or negative experiences with similar situations or events. 
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Generalized expectancy theory and LOC could help practitioners determine a reason for 
ongoing drug use or sustained abstinence.  
The use of the DRLOC scale at the beginning, during, and at the end of treatment 
could help measure shifts in thought processes, behaviors, and quality of life (Pasareanu, 
Opsal, Vederhus, Kristensen, & Clausen, 2015). Men and women who used narcotics or 
stimulants as their primary drug could benefit from learning their DRLOC score.  
Nature of the Study 
The current study is a preexperimental static group comparison. The DRLOC 
instrument measures thought processes associated with drug use. I extracted from the 553 
participants in Hall’s study a subset of 402 participants to conduct secondary analysis of 
data from participants who completed the DRLOC instrument and identified a narcotic or 
stimulant as their primary drug. The purpose for identifying narcotics and stimulants was 
they were the most abused drugs in the United States (SAMHSA, 2016c), and has been 
identified as the most abused drugs upon admission into treatment programs in California 
(CDADP, 2013; SAMHSA, 2016d).  
I obtained permission from Hall and representatives at the UCLAs Integrated 
Substance Abuse Programs to use the data generated from the DRLOC study (see 
Appendix A). For this study, the dependent variable was DRLOC score, in which a score 
of one indicated an internal LOC and a score of two indicated an external LOC. The 
independent variables were primary drug (narcotic or stimulant) and gender (male or 
female). The primary analysis was a 2x2 full factorial ANOVA. To describe the sample, 
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age, race, socioeconomic status, and education level were reported. If any of these 
demographic variables are found to be related to the DRLOC score, they were included 
as a covariate in the primary analysis. Operationalization of all variables is detailed in 
Chapter 3.  
Definition of Terms 
The following clarifies and defines the words used in the study.  
Addiction: Addiction is a brain disorder or neurological disease caused by 
molecular changes in the brain when foreign chemicals are introduced into the body’s 
system (APA, 2013).   
Addictive Behaviors: Addictive behaviors consists of impulsive and compulsive 
actions and reactions associated with drug use due to peoples’ inability to self-regulate or 
control their impulses when faced with internal and external stimuli (Rotter, 1966; 
Sheffer et al., 2012; Webb et al., 2010). These biopsychosocial patterns of addictive 
behaviors include ongoing substance use or impulsive and compulsive patterns of 
maladaptive behaviors despite disruptions to the family system, social relationships, 
educational achievement, and employment obligation.  
Dopaminergic System, Serotonergic System, Mesocorticolimbic System, and 
Endogenous Opioid Systems: These systems are different areas of the brain that produce 
neurotransmitters to communicate from one region of the brain to another. These systems 
are part of the reward circuitry responsible for reinforcing and maintaining addictive 
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behaviors (Karim & Chaudhri, 2012; Leeman & Potenza, 2013; Neto & True, 2011; 
Niehaus et al., 2009).  
Generalized Expectancy Theory: A person develops expectations for a present 
situation by comparing similar events or outcomes that occurred in the past. It is during 
past experiences that patterns of behaviors and anticipation determine how one would 
respond to similar experience in the future (Rotter, 1966).  
Locus of Control: Locus of control is a person’s ability to believe he or she had 
some control or no control over the outcome of a situation or event (Rotter & Mulry, 
1965). 
Narcotics: Narcotics consists of opium, morphine, hydromorphone, codeine, 
oxycodone, hydrocodone, tramadol, buprenorphine, methadone, meperidine, pentazocine, 
propoxyphene, and any other drug with morphine-like effects (SAMHSA, 2016c).    
Primary Drug: The primary drug is a person’s preference for a particular drug 
(SAMHSA, 2016c).  
Stimulants: Stimulants consists of amphetamines, Methamphetamines, cocaine, 
and crack cocaine (SAMHSA, 2016c). 
Substance Use Disorder: Substance use disorders are neurological diseases 
defined as physiological and psychological dependence on foreign chemicals introduced 
into the body (Buckland, 2008; Caan, 2012; Carlson & Larkin, 2009; Congdon & Canli, 
2008; Davidson et al., 2008; Shor & Levit, 2012). The dependence on these foreign 
chemicals interferes with a person’s ability to function socially, causing significant 
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biopsychosocial impairment and maladaptive behaviors that negatively impact the 
person’s quality of life (Buckland, 2008; Caan, 2012; Carlson & Larkin, 2009; Congdon 
& Canli, 2008; Davidson et al., 2008; Shor & Levit, 2012).  
Assumptions 
I used secondary data generated from UCLAs Integrated Substance Abuse 
Programs that conducted two studies with the same population. The original study was 
the Drug Treatment Process and Drug Treatment Counselor Practices and Effectiveness 
(Hall, 2001). From this population, a second study was conducted by Hall (2001), the 
Feelings About Drug Use, Drug Related Locus of Control (DRLOC). UCLAs Integrated 
Substance Abuse Programs recruited participants from 19 treatment programs within Los 
Angeles country representing five treatment modalities: inpatient programs, outpatient 
programs, residential programs, day programs, and methadone maintenance treatment 
programs (Hall, 2001). 
Davis, Doherty, and Moser (2014) indicated the need to present oneself in a 
favorable way to make a positive impression or to exaggerate responses to feel socially 
acceptable are all concerns when administering self-report instruments like the DRLOC 
scale. I assumed all participants in the original UCLAs Integrated Substance Abuse 
Programs’ study and Hall’s Feelings About Drug Use, DRLOC study were truthful with 
their responses to questions on the DRLOC scale. I also assumed the programs under the 
UCLAs Integrated Substance Abuse Programs did not coerce participants to be involved 
in one or both studies or made them feel obligated to participate. It is noteworthy, some 
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participants from the original UCLAs Integrated Substance Abuse Programs’ study 
declined to participate in the Feelings About Drug Use, DRLOC study (Hall, 2001).  
Scope and Delimitations 
The current study used secondary data generated from the Drug Treatment 
Process and Drug Treatment Counselor Practices and Effectiveness study and the 
Feelings About Drug Use, DRLOC study conducted by the UCLAs Integrated Substance 
Abuse Programs (Hall, 2001). These studies represented a sample of 19 different 
programs from five different treatment modalities whose participants were tested for 10 
identified abused drugs. The Drug Treatment Process and Drug Treatment Counselor 
Practices and Effectiveness study included 666 participants. The Feelings About Drug 
Use, DRLOC study included 553 participants. I used data from the Feelings About Drug 
Use, DRLOC study to examine DRLOC scores of 553 participants (men and women). I 
identify a subset of 402 participants who indicated either a narcotic or stimulant as their 
primary drug. My focus was to determine if primary drug used among men versus 
women effect the DRLOC score.  
Generalized outcomes associated with prior addictive behaviors could influence 
the patient’s belief system, which may be directly related to the primary drug. This could 
imply a connection between cause and effect. I only seek to explore an association 
between the three variables (gender, primary drug, and LOC score) but not whether a 
cause and effect relationship exists. Any appearance of a cause and effect association is 
coincidental.  
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Limitations 
Hall’s (2001) Feelings About Drug Use, DRLOC study provided an overview of 
the methodology, procedure, and instruments administered during the UCLAs Integrated 
Substance Abuse Programs’ study, titled Drug Treatment Process and Drug Treatment 
Counselor Practices and Effectiveness. However, detailed procedures on how the 
instruments were administered were not provided. I limited my investigation to the 
information provided by Hall’s 2001 report on the Feelings About Drug Use, DRLOC 
study, which used the original data generated by UCLAs Integrated Substance Abuse 
Programs’ study. 
Limitations involving participants’ reading and writing abilities were a concern. 
SAMHSA (2012) indicated 64.1% of people with an addiction finished high school. I 
was not able to locate information indicating the comprehension level of the DRLOC 
scale or the I-E LOC scale. Rotter’s I-E LOC study recruited college students. In Hall’s 
study, there were no indications whether interviewers read to participants and then 
completed the instrument by marking the answers provided, or if each participant 
independently completed the surveys and questionnaires provided to them by the 
interviewers. Hall’s (2001) report did indicate the education level of those who 
participated in the UCLAs Integrated Substance Abuse Programs’ study averaged 12.2 
years.  
Threats to internal validity were also a major concern. People with addictive 
behaviors often demonstrated a lack of responsibility, such as not keeping appointments 
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or not following through with completing studies. Hall (2001) documented there were 
666 participants in the UCLAs study, of which 565 participated in the DRLOC study and 
101 participants declined. Hall’s report also indicated there were participants who did not 
complete all 15 items on the DRLOC scale. Hall did not note the reasons why those who 
participated in the study did not complete all 15 items. Hall did not document the exact 
number of incomplete instruments. Hall did include instruments with at least 12 of 15 
items completed in the final analysis.  
There might be a potential threat to internal validity as participants are patients in 
programs directly affiliated with UCLAs Integrated Substance Abuse Programs. The 
phenomenon of patients giving socially appropriate responses compared to honest 
responses representative of their addictive behaviors, counseling experience, and thought 
processes could affect internal validity. Therefore, potential information bias could have 
been present. It is not clear from Hall’s (2001) report if participants of the UCLAs 
Integrated Substance Abuse Programs’ study were required to respond due to their 
affiliation with the UCLAs Integrated Substance Abuse Programs. However, what is 
clear from Hall’s (2001) report is there were participants who declined to participate in 
the follow-up study, Feelings About Drug Use, DRLOC. 
Extraneous and confounding variables from biopsychosocial triggers in the 
environment are other issues of concern regarding threats to internal validity. These 
variables could have influenced behaviors and thought processes and thereby effected 
responses to questions given in the UCLAs Integrated Substance Abuse Programs’ study 
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and Hall’s DRLOC study. An example of an extraneous variable could have been 
participants under the influence of drugs while completing the DRLOC instrument. 
Significance of the Study 
Addiction is a multidimensional disease with complex habitual behaviors (Caan, 
2012; Carlson & Larkin, 2009). Researchers determined all types of addictions are 
similar in their etiology, functionality, physiological and psychological withdrawal 
processes, and neurobiological effects at a cellular level (Gifford & Humphreys, 2007; 
Grant et al., 2010; Heidbreder, 2008; Niehaus et al., 2009). Furthermore, addiction 
impacts behavior (Gifford & Humphreys, 2007; Heidbreder, 2008; Niehaus et al., 2009) 
and stages of recovery (DiClemente, 2003; Norcross et al., 2011). By understanding the 
thought processes of people with an addiction clinician could better address addictive 
behaviors with appropriate evidenced based interventions. 
The focus of this study was threefold: to examine if narcotic or stimulant used 
among men and women effect the DRLOC score, to address Hall’s (2001) question 
related to gender and external LOC score, and to enhance the body of work that Hall 
(2001) and Ersche et al. (2012) presented by determining if there is usefulness in 
implementing the DRLOC scale as an individualized instrument to be included in the 
treatment process. Implementing the DRLOC instrument at the time of admission, during 
treatment, and toward the end of treatment (Pasareanu et al., 2015) could potentially help 
measure patient’s progress in treatment through personal awareness and shifts in thought 
processes and behaviors, or the lack thereof. The DRLOC scale could provide a 
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reasonable understanding of the minimal progress achieved and it could help determine 
the appropriate interventions needed that coincide with the patient’s LOC score.  
The results of this study could have significant social change implications for the 
addiction, medical, and mental health fields due to a potential increase in understanding 
the interdependency of I-E LOC and primary drug used by patients receiving treatment 
for substance use disorders. This approach supports the need for practitioners and patients 
to work together to develop interventions throughout treatment as they address addictive 
behaviors. By understanding the LOC score, practitioners and patients alike could 
recognize addictive behaviors better and make decisions regarding intervention strategies. 
Implementing the DRLOC scale as an integral part of treatment seemed to be a natural 
next step in the field of addiction to assess how people view their control, or lack thereof, 
over addictive behaviors.  
Social Change Implications 
 When addressing addiction as a social problem, it is important to 
understand the disorder as a multifaceted disease that effects not only the individual but 
loved ones and the broader society. The social implication of utilizing the DRLOC 
instrument in treatment programs and educating patients about their DRLOC score could 
help patients become aware of their LOC and gain an understanding of how their ongoing 
drug use was connected to how they viewed a situation and prior experiences and what 
might have been their triggers. This awareness could help patients recognize and avoid 
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places, people, and things that contribute to relapses, thereby helping patients shift from 
using drugs toward gaining and maintaining abstinence.  
Foon (1986) suggested practitioners administer a LOC instrument as part of 
family therapy with each family member. Foon asserted a better understanding of a loved 
one’s addictive behaviors and level of control toward drug use exists when each family 
member is aware of their own LOC score and how this impacts their interactions with 
others. Being aware of one’s LOC score may help family members change their 
perception and the stigma associated with addictions (Foon, 1986).  
Addiction is seen as a socially pejorative term with stigmatizing connotations, 
such as drug addict and dope fiend (Davidson et al., 2008). Social implications from the 
general public becoming educated about LOC and one’s personal score could help the 
public recognize their thought processes associated with daily responses to events and 
situations. This awareness could result in positive shifts in how the public view and treat 
people with a substance use disorder (Davidson et al., 2008; Karim & Chaudhri, 2012; 
McLachlan & Starkey, 2012). 
Sigma that exists in the medical and mental health fields was addressed by 
Davidson et al. (2008), as well as Larkin et al. (2006). They suggested encouraging 
professionals in the medical and mental health fields to start addressing patients as 
individuals who are experiencing an addiction and not to focus exclusively on the 
addiction controlling the individual. For example, Davidson et al. (2008) suggested 
saying people with an addiction instead of saying heroin addicts as more appropriate 
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language. The social implication of using person-first allowed for an understanding of the 
disorder as a disease instead of a disorder out of one’s control (Davidson et al., 2008).  
 Social implications for treatment programs that administer the DRLOC scale 
could be beneficial for measuring treatment success. Obtaining the DRLOC score during 
the initial admission could help with selecting appropriate treatment interventions at the 
beginning of treatment. When administering the DRLOC scale halfway through 
treatment, the score could help practitioners and patients better recognize the thought 
processes behind addictive behaviors and how to control them. The score could then help 
to determine if adjusting interventions during the treatment process is needed. When 
administering the DRLOC scale toward the end of services, the score could help to 
measure progress or lack thereof and provide an informed discharge plan (Connolly, 
1980).  
 Foon (1986) concur with using an individualized assessment instrument such as 
the DRLOC scale as a pre and post-assessment tool to help the practitioner gauge the 
thought processes of the patient. By obtaining the patient’s LOC score, practitioners and 
other professionals in addiction, medical, and mental health settings could better 
understand the psychological dependence that drives ongoing drug use at an 
individualized level (Foon 1986). Furthermore, by understanding the thought processes of 
patients, practitioners could develop treatment interventions based on where patients are 
in their thought processes, either internally or externally (Foon, 1986).  
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 According to Rotter and Mulry (1965), patients with an internal LOC score would 
more likely attend treatment programs regularly, work at strengthening coping skills, 
have a willingness to learn more about their addiction and addictive behaviors, would 
remember information that helped them in their recovery, and would work harder at 
setting and achieving goals. Rotter and Mulry (1965) further explained patients with an 
external LOC score would take longer to work on cognitive and behavioral skills as they 
learn to accept responsibility for addictive behaviors.  
A more progressive practice, according to Foon (1986), is to administer a LOC 
instrument for practitioners as well as patients. Utilizing a LOC instrument for both 
professionals and patients would help to minimize stigma in treatment settings (Foon, 
1986). For example, making practitioners aware of their external LOC would help them 
work on shifting their thought processes toward an internal LOC, or matching an internal 
thinking professional with an internal thinking patient could increase favorable results 
(Ersche et al., 2012).  
Social implications for clinicians in multiple human service fields and community 
organizations could benefit by knowing the DRLOC score that could then be aligned with 
appropriate evidence-based interventions (National Registry of Evidence-based Programs 
and Practices, 2016). Implementing these interventions could help shift negative 
behaviors toward positive behaviors, thereby reducing the human cost associated with 
substance use, medical care, mental health treatment, family services, and legal issues 
(Caan, 2012; Kreek et al., 2005). For example, the National Institute on Drug Abuse 
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[NIDA] (2014) reported how maintaining a sober life could assist with establishing 
stability, thereby potentially decreasing incidents of domestic violence and other criminal 
activity, along with increasing productivity in the workplace. Retention in treatment 
could positively influence personal health and safety associated with accidents, 
unintentional overdoses, and premature deaths (Kreek et al., 2005; NIDA, 2014). 
According to Hatgis, Friedmann, and Wiener (2008), college students who used drugs 
had lower grades, were less likely to participate in extracurricular activities, sought 
mental health services, and were more sexually active than students who did not use 
drugs.  
In 2014, NIDA published a report indicating family members spent billions of 
dollars to have loved ones treated by doctors, teachers, social workers, counselors, and 
volunteers who worked in the field of addictions, medical, mental health, and in 
community organizations. By finding innovative ways to address substance use disorders 
and developing appropriate interventions to treat patients, the United States could 
generate a savings of up to 12 times the costs of not providing individualized treatment 
(NIDA, 2014). Stanforth, Kostiuk, and Garriott (2016), suggested the implementation of 
a LOC scale could help guide appropriate treatment interventions that deter addictive 
behaviors and cause positive social change to monetary costs of health care, legal, and 
educational institutions.  
In conclusion, the results of this study could have positive social change 
implications for the patient, family members, the general public, practitioners in 
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treatment programs, and clinicians in health care fields. Including the DRLOC scale as 
part of a practice of integrating evidence-based treatment with empirical assessments 
could help identify internal and external thought processes associated with addictive 
behaviors and substance use disorders. 
Summary 
Addiction is a chronic relapsing disease that could develop into a substance use 
disorder that causes significant cognitive, behavioral, and social impairment and 
negatively effects a person’s quality of life (SAMHSA, n.d.). These negative effects are 
responsible for social stigma related to substance use disorders (Davidson et al., 2008). A 
social movement to shift public opinions away from a negative view of addiction toward 
a positive view of people with substance use disorders was supported by Davidson et al. 
(2008), Karim and Chaudhir (2012), and McLachlan and Starkey (2012).  
Over the years, substance use disorders reached an epidemic level (Baird, 2015; 
Rollins, 2016; Worley et al., 2015). UNODC (2015a) estimated that globally162 to 324 
million people in 2012 used illicit drugs. In the United States, between 2008 and 2012, 
23.9 million Americans reported using illegal drugs (Cummins et al., 2009; SAMHSA, 
2013a). In 2012, California reported 947,000 people abused illicit drugs, but only 
115,000 received treatment. California had the highest number of treatment programs in 
the United States during 2011 to 2012 (CDADP, 2013). Methamphetamine was the most 
commonly reported drug as the primary drug at the rate of 13% higher than heroin 
(CDADP, 2013).  
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Caan (2012) and Congdon and Canli (2008) noted the development of addictive 
behaviors is complex. Rotter (1966) used generalized expectancy theory to explain the 
positive and negative experiences that determined whether people would generalize their 
current experience or reinforce them using an internal or external belief system. Rotter 
(1966) reported impulsive people would respond according to the outcome they expect to 
occur, while others would respond feeling they had no control over the outcome. Rotter 
and Mulry (1965) termed this belief system LOC and created the I-E LOC scale to 
measure internal and external LOC.  
The purpose of conducting a pre-experimental quantitative study was to explore 
the effect gender and primary drug use had on DRLOC score. Hall (2001) developed the 
DRLOC scale to measure LOC in people with substance use disorders. Chapter 2 
provides more details about the potential relationship between LOC as an underlying 
force that might be driving addictive behaviors in people with substance use disorders. 
Scores from the DRLOC scale of men and women identified as abusing narcotics or 
stimulants as their primary drug were the targeted population for this study. In Chapter 3, 
I review my methodological choices, as well as procedures I used to collect and analyze 
the data.  
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Chapter 2: Literature Review 
There are many ways to approach treatment of a substance use disorder in the 
addiction, medical, and mental health fields. Pasareanu et al. (2015) stressed the 
importance of using pre and post assessments as an integral part of measuring treatment 
interventions and success. Hall’s DRLOC scale is a useful tool as an integral part of the 
treatment process, and as a pre and post assessment instrument for measuring patient’s 
cognitive awareness of drug-related behaviors and shifts in thought processes.  
The purpose of conducting a preexperimental quantitative study was to explore 
the effect gender and primary drug use had on DRLOC scores.  My study used data from 
the UCLAs Integrated Substance Abuse Programs’ Drug Treatment Process and Drug 
Treatment Counselor Practices and Effectiveness and the Feelings About Drug Use, to 
measure (LOC) by examining the DRLOC score of participants who identified narcotics 
or stimulants as their primary drug. The DRLOC scale is an assessment instrument used 
to measure LOC in people diagnosed with a substance use disorder. In this chapter, I 
provided an in-depth literature review of various related topics, including an explanation 
of the theoretical foundation and conceptual framework that provides a firm basis for the 
study. I also included the use of the DRLOC scale as a pre and post assessment tool and 
the development of the DRLOC instrument. 
Literature Search Strategy 
A search using addiction related terms and phrases to conduct a literature review 
required the use of Walden University’s library to access the following databases: 
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PsycINFO, PsycARTICLES, Mental Measurements Yearbook, Health and Psychosocial 
Instruments, SocINDEX, Google Scholar, and ERIC. Other resources included domestic 
and international organizations, such as the APA, NIDA, National Institute of 
Neurological Disorders and Stroke, National Registry of Evidence-Based Programs and 
Practice, and the UNODC. I downloaded the latest SPSS Version 23 for Windows from 
Walden University’s Library to perform statistical analysis of the variables. 
The key search words, terms, and authors consisted of the following: Whiteside 
and Impulsivity, Cyders and Impulsivity, Lynam and Impulsivity, Rotter and Locus of 
control, Lefcourt and locus of control, and Hall and locus of control. The following word 
search included addiction, addictive behaviors, behavioral addictions, chemical 
dependency, substance abuse, stimulants, cocaine, Methamphetamine, narcotics, heroin, 
and methadone. Some key phrases that were searched to provide information about the 
topics included stimulant addiction, cocaine addiction, Methamphetamine addiction, 
opiate dependence, prescription abuse and addiction, and addiction and theories. Other 
word searches and phrases included models of treatment for addictions such as 
alternative treatment and methadone, models of treatment for recovery, treatment 
programs and theories, interventions for addiction treatment, and evidence-based 
practices. Word searches and phrases also included stages of development, dropout rate 
and treatment, addiction and retention, addiction and attrition, treatment outcome, 
cognitive behavioral therapy, mindfulness, self-help programs, neurological disorders 
and substance abuse, substance use and mental disorders, reward and addiction, genetics 
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and addiction, addiction and brain, addiction and dopamine, addiction and serotonin, 
addiction and opioid receptor, contingency and substance abuse, impulsivity and locus of 
control, substance abuse and expectancy, addiction and locus of control, self-control and 
addiction, free will and addiction, locus of control and free will, external control and 
addictions, internal control and addiction, mental health and addiction, co-occurring 
disorders and addiction, social change and addiction, coping skills and addictions, 
recovery and addiction, men and women and drug use, men and women and substance 
abuse, gender and substance use disorders, gender and substance abuse, gender and 
drugs, gender and mental health, gender and medical, gender and physical health, 
gender, substance abuse, and mental health, and gender, substance abuse, and medical. 
The scope of the literature search covered the etiology of addiction, addictive behaviors, 
and treatment for substance use disorders. I also reviewed theories and concepts related to 
locus of control constructs and generalized expectancy theory and the influence that 
generalized expectancy theory and locus of control have on men and women with 
substance use disorders.  
Theoretical Foundation 
Generalized expectancy theory is a social learning theory combining aspects of 
reinforcement and cognitive theories to explore the complex nature of human behaviors.  
The theory provided a basis for comparing cognitive and behavioral responses to 
environmental stimuli (Rotter, 1966). Rotter (1966) suggested generalized expectancy 
theory determined how much experience people had in their environment with similar 
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results, and whether these previous experiences positively or negatively reinforced a 
belief system which placed value on an anticipated outcome. The theory provided a 
theoretical foundation for examining the constructs of LOC as related to addiction.  
Generalized expectancy theory consists of three elements. The first element is 
similarity reinforcement and situational reinforcement. Similarity reinforcement happens 
when parallel experiences occur which yield the same outcomes (Rotter, 1966). When 
referring to a person with substance use disorders, not only is the stimulus (drug of 
choice) available as reinforcement, so is the behavioral response (drug seeking). Thus, 
the experience of using the drug creates a level of expectancy with each similar 
experience of obtaining the primary drug. For example, a person may travel across town 
to an area to seek out a drug dealer and buy heroin. In the past, each time the person 
performed this behavior, he or she was successful in accomplishing the goal of finding a 
dealer, buying the drug, and then using it. One day the person meets a different dealer 
selling the drug, or the person might have to visit a different corner to find a dealer. 
Regardless of how the person obtain the drug, the experience is likely to be similar 
enough to result in the same outcome of obtaining the primary drug, thereby reinforcing 
the behavior of seeking out the drug in the future.  
Situational reinforcement develops from a set of conditions that vary and require 
decision-making or problem-solving each time it happens. With situational 
reinforcement, not only does the stimulus work as a reinforcer, but it initiates a 
behavioral response (Rotter, 1975). When a person refrains from drug use and accepts 
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abstinence as a developing skill, the person will initiate problem-solving when he or she 
begins to desire using a primary drug. For example, when unexpectedly confronted with 
the opportunity to share heroin with friends, the person would start to process or problem 
solve about the consequences of submitting to drug use. The person may consider the 
ramifications of using the drug, which could include starting to use regularly. This could 
lead to an increase and frequency of drug use over time. 
The second element of Rotter’s (1975) generalized expectancy theory is the value 
of the reinforcement. For example, a person traveling across town to a specific house to 
buy Methamphetamine would expect the drug dealer to be there. Because the dealer had 
always been there in the past, the drug dealer’s presence at the house and being able to 
buy Methamphetamine to relieve withdrawal symptoms holds a greater value to the 
person than not traveling across town to buy Methamphetamine, and thus, suffering 
withdrawal symptoms. Each time the person relieve symptoms of withdrawal, 
Methamphetamine becomes more valuable or more rewarding than not seeking it. The 
reward serves to reinforce the continued drug-seeking behavior (Rotter, 1975; Skinner, 
1976; Watson, 1970). 
The final element of Rotter’s (1966) generalized expectancy theory is the 
psychological situation that has an impact on expectancies and reinforcement values. In 
other words, psychologically, a person’s LOC intervenes and influences his or her belief 
in the ability to control outcomes. Given the elements of generalized expectancy theory, 
one could predict that during treatment patients with addictive behaviors would start to 
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refrain from drug use by avoiding triggers once they are able to recognize the role of 
generalized expectancy and LOC. 
Review of the Literature  
In the United States, the identifiable label for a person who experiences chronic 
relapses is an addict, implying addiction is the primary focus and the individual is 
secondary (Davidson et al., 2008). What identifies a person as being an addict, or a 
person with an addiction, is compulsive drug-seeking and impulsive drug-related 
behaviors and ongoing drug use despite negative biopsychosocial consequence (Niehaus 
et al., 2009). Schmitz (2005) found the use of the word addiction in the public domain 
describes a person’s overuse or misuse of some item or food, or an obsession with a 
person or a thing, thereby devaluing the scientific definition of addiction. Schmitz (2005) 
further indicated that professionals in the field used the term addiction to address 
substance abuse and substance dependence as presented in the Diagnostic and Statistical 
Manual of Mental Disorders IV, Text Revision (APA, 2000). However, this did not 
address the growing understanding of the role neuro-circuitry had in the development of 
addictions. Therefore, to avoid the misuse of the term addiction by non-professionals in 
the public domain, and to assure that professionals across disciplines shared the same 
understanding of what is an addiction, the Diagnostic and Statistical Manual of Mental 
Disorders IV, Text Revision, did not include a category titled addiction (APA, 2000; 
Schmitz, 2005).  
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In presenting a universal definition to guide all professionals, the Diagnostic and 
Statistical Manual of Mental Disorders IV, Text Revision, provided a more specific 
definition that identified addiction as being a dependence on, the abuse of, and 
withdrawal from a foreign chemical not naturally produced in the body (APA, 2000; 
Schmitz, 2005). To establish global consistency about what is an addiction, in 1969, the 
World Health Organization discontinued the use of the word addiction and replaced it 
with the term drug dependence to capture the physiological and psychological state of 
dependence developed from the abuse of substances (Lubman, Yucel, & Pantelis, 2004). 
Additionally, in 2011, the American Society of Addiction Medicine presented a 
definition of addiction reinforcing it as being a brain disease based on the body of 
research focused on neurobiological aspects (Cann, 2012). 
Researchers agreed addiction is more than just the use of a substance; they 
defined it as a pattern of maladaptive behaviors (Grant et al., 2010). It is now widely 
accepted that there are two categories of addictions: Chemical addictions relate to foreign 
substances introduced into the body causing neurological changes at a molecular level 
(Buckland, 2008; Caan, 2012; Shor & Levit, 2012), and the process of behavioral 
addictions that are developed from patterns of impulsive and compulsive behaviors 
(Grant et al., 2010; Karim & Chaudhri, 2012). Both types of addictions share commonly 
identified biopsychosocial and behavioral features in the areas of development, 
maintenance, treatment, and recovery (Grant et al., 2010; Leeman & Potenza, 2013; 
McLachlan & Starkey, 2012).  
37 
 
The Diagnostic and Statistical Manual of Mental Disorders 5 (APA, 2013) 
reflected the acceptance of behavioral addictions as a serious disorder and added it as a 
category, Non-Substance Related Disorders, along with Substance-Related Disorders, for 
chemical addictions. An example of a behavioral addiction is compulsive shopping. A 
report by Karim and Chaudhri (2012) examined compulsive shopping among men and 
women. The results revealed no significant difference in behaviors with men at 5.5% and 
women at 6.0% and implied the disparity between gender and behavioral addictions 
might be small. 
The definition of addiction provided in the Diagnostic and Statistical Manual of 
Mental Disorders 5 is, “a foreign chemical being introduced into the body causing acute 
or chronic neurobiological changes that develop into neurological dependence, 
physiological reactions from the exposure of foreign chemicals introduced into the 
body’s system, chronic relapses resulting from attempts to stop using foreign chemical, 
psychological symptoms affecting shifts in thought processes, and behavioral problems 
that negatively impacts the person’s quality of life” (APA, 2013, p.585). These changes 
in the body are responsible for addictive behaviors, which include patterns of obsessive 
drug seeking, continued impulsive drug use, and repeated relapses (Bao et al., 2009). A 
level of dysfunction occurs when people lose control over their ability to act and think 
rationally regardless of consequences to their health, family and social interactions, and 
productivity with educational and vocational endeavors (Bao et al., 2009; Gifford & 
Humphreys, 2007; Grant et al., 2010). There were 25 million people in the United States 
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who used a chemical substance and were susceptible to developing a substance use 
disorder (Baird, 2015).  
Researchers in the field of addiction recommended using the scientific approach 
to address substance use disorders by focusing on behavioral issues influenced by 
compulsive patterns of behaviors (Gifford & Humphreys, 2007; Karim & Chaudhri, 
2012; Norcross et al., 2011) while others examined environmental and genetic factors 
(Kreek et al., 2005; Lubman et al., 2004). Separately, other researchers embraced a 
neurobiological model to explain addiction (Erickson & White, 2009; Leeman & 
Potenza, 2013).  
Despite advancements in the field of addiction, the stigma associated with 
addiction carries a negative social label. This social attitude creates barriers for many 
who suffer from substance use disorders that hinder them from seeking formal or 
informal treatment (Kulesza et al., 2016). Gender discrimination associated with 
addiction also holds a stigma, but racism, sexism, and other status characteristics that 
historically marginalized people also contribute to barriers when treating people with a 
substance use disorder (Kulesza et al., 2016). 
The United States tend to see substance use disorders as the result of illegal drug 
use, but not all substance use disorders start from illegal drug use. Legal drugs, such as 
alcohol, nicotine, prescription narcotics, and prescription stimulants could develop into a 
dependence resulting in addictive behaviors, and then addictive disorders (Davidson et 
al., 2008). Davidson et al. (2008) discussed how the stigma surrounding addiction is an 
39 
 
image of shady characters with no impulse control who steal from family and friends, use 
dirty needles, and hide in darkness. Davidson et al. also included homeless people who 
cannot not seem to function properly in society. Rarely does the stigma related to 
addiction take into account certain segments of society, which do not fit into the category 
of an addict, such as people living in high socioeconomic areas or those who hold 
positions of authority and respect in organizations and institutions (Davidson et al., 
2008).  
For example, the younger population might develop an addiction to substances 
stemming from peer pressure (NIDA, 2014). This population includes middle school, 
high school, and college students attending weekly parties consuming alcohol, narcotic 
and stimulant pills (NIDA, 2014). Davidson et al. (2008) suggested not only are younger 
people susceptible to potential dependence and addiction but also the elderly, relatives, or 
people we trust, such as police officers, nurses, and teachers, even grandparents. Their 
struggles begin when they develope a dependence on prescription narcotics in the 
aftermath of recovering from a serious surgery. As the population in the United States 
ages, we will face an increase of substance use disorders among patients 60 years and 
older with limited treatment programs equipped to address their concerns (Davidson et 
al., 2008); approximately 5.4% of elderly patients used illegal drugs (Morgen, Denison-
Vesel, Kobylarz, &Voelkner, 2015). SAMHSA (2016c) reported the oldest person in 
treatment for narcotic abuse was 68.8 years old and the oldest person in treatment for 
stimulant abuse was 78.1 years old. Given the right conditions and circumstances, we are 
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all susceptible to developing a dependence on prescription medication or a legal 
substance along with addictive behaviors associated with the need to alleviate pain or 
discomfort (Davidson et al., 2008). 
The Centers for Disease Control and Prevention (2016) conducted a longitudinal 
study from 2000 to 2014, that demonstrated the prevalence of opiate prescriptions abuse 
in the United States. According to the report, opiates, such as oxycodone, morphine, 
fentanyl, and other narcotic-based medications, were highly addictive and misused or 
diverted; meaning the patient is not taking the medication as prescribed or is giving away 
or selling the medication to other people. The misused or diversion of prescription 
medications caused 500,000 deaths or 78 fatalities each day due to opiate overdose. 
Furthermore, SAMHSA (2016a) indicated 50.5% of opiate abusers got pills from family 
and friends, and 22.1% got their pills directly from their physician.  
The Center for Behavioral Health Statistics and Quality (2015) reported 1.6 
million people in the United States abused prescription stimulants, of which 569,000, 
reported using homemade Methamphetamine. SAMHSA’s (2016c) 10-year study of 
1,614,358 admissions into treatment programs found only 6% were for 
Methamphetamine and amphetamine in 2004. However, by 2014, admissions for 
Methamphetamine and amphetamine as a primary drug increased to 9%. SAMHSA 
(2016c) reported 54% of admissions for Methamphetamine and amphetamine in 2014 
were males with an average age of 33 years old, 67% were White, 18% were Hispanic, 
and 4% were Black. Additionally, SAMHSA (2016c) reported that 61% preferred to 
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smoke Methamphetamine and amphetamine, and 26% preferred injections as their 
primary route, while 8% preferred inhalation.  
Some people used legal or illegal drugs once or occasionally and then never used 
them again. There are also those who used legal or illegal drugs repeatedly and risked 
becoming physiologically and psychologically dependent (Kreek et al., 2005; Lubman et 
al., 2004). Nielsen et al. (2008) attributed this difference to some people having a genetic 
predisposition; two-thirds of the people who used opiates do not experience signs of 
addiction.  
The stigma of seeing patients as addicts and not associating their addictions with a 
neurological disease resulted in the need for Davidson et al. (2008) to advocate for social 
change. This change started with the addiction industry and the healthcare field. 
Davidson et al. (2008), as well as other researchers, such as Larkin et al. (2006), 
encouraged individuals, organizations, and the healthcare field to demonstrate a positive 
shift in the words they chose to use and the way they treat patients with addictions. They 
encouraged practitioners in the helping professions to become more person-centered. 
Person-centered is treating people as individuals, thereby providing individualized 
treatment plans and not generic interventions (Larkin et al., 2006).  
Incorporating the person-centered approach across mental health and addiction 
settings could help diminish the stigma associated with substance use disorders, thereby 
allowing more people to accept their disorder and then seek treatment without feeling 
ostracized. Nonetheless, regardless of how professionals define the word addiction, and 
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the different approaches to treating the disorder, the stigma associated with addiction 
continued to permeate the United States as the number of people who reported abusing 
drugs outnumbered the reported number of patients that entered treatment (CDADP, 
2013; SAMHSA, 2013a; UNODC, 2015a). For example, Baird (2015) documented there 
were 25 million Americans identified with an addiction, but only 1.6 million received 
treatment for a substance use disorder (SAMHSA, 2016c).  
Gifford and Humphreys (2005) and Heidbreder (2008) offered reasons for 
people's continued chemical or behavioral addiction. They suggested the desire to repeat 
the initial euphoric experience initiated a reinforcing response. When exposed to the 
chemical, activity, or object a second time, people experienced sensations of satisfaction 
but not at the level of the initial introduction. The need to experience the initial level of 
euphoria developed into patterns of maladaptive behaviors associated with seeking out 
and repeating the use of the chemical, activity, or object.  
Gifford and Humphreys (2007) reported patients could experience a chemical 
addiction while also struggling with a behavioral addiction. For example, patients could 
experience addiction to opiates while also struggling with gambling and compulsive 
shopping. If the primary addictive disorder remains untreated, it could become difficult to 
treat other identified addictive disorders, therefore, treating various addictive behaviors 
requires assessing the target of what drives the patterns of maladaptive behaviors in 
individuals (Gifford & Humphreys, 2007). These assessments must also identify the 
relationship between the function of the addictive behaviors and the environment 
43 
 
(Gifford & Humphreys, 2007). The DRLOC scale is an instrument that aids in measuring 
thought processes leading to maladaptive addictive behaviors and could potentially serve 
as a tool for pre and post assessment.  
An extensive review of the literature revealed studies examining impulsiveness 
and a person’s LOC, as it relates to substance use disorders. Altamirano et al. (2011) 
examined the relationship between impulsivity, LOC, and chemical addictions. They 
researched the use of the drug naltrexone that doctors prescribed to treat alcoholism. The 
researchers revealed participants with an internal LOC demonstrated an increase in 
impulsivity while taking naltrexone. Participants identified with external LOC had an 
opposite effect and demonstrated less impulsivity while on the medication.  
Sheffer et al. (2012) examined nicotine dependence and LOC in a population with 
low socioeconomic status. The researchers revealed the population tended to have an 
external LOC and greater stress. The researchers concluded the targeted participants 
would most likely not achieve abstinence from tobacco after completing a treatment 
program. Furthermore, their study demonstrated external LOC reinforced impulsive traits 
that hindered abstinence. (Sheffer et al., 2012).  
Bornovalova et al. (2005) examined the effects of both narcotic and stimulant use 
on behavior. They found chronic stimulant use could cause neurological damage which 
impairs judgment and decision making. 
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The Etiology of Substance Use Disorders 
Understanding the mechanisms responsible for substance use disorders is 
important, as every individual enters treatment with their own complex biopsychosocial 
history (Gifford & Humphreys, 2007). This history could include a combination of 
genetic factors, environmental influences, and neurological changes in cognitive 
processes (Gifford & Humphreys, 2007; Grant et al., 2010; Nielsen et al., 2008). 
Different researchers have varying perspectives of what causes substance use disorders 
(Heidbreder, 2008). For example, Buckland (2008) theorized either genetic, environment, 
biology or personal experiences could make one person more susceptible than another. 
What is agreed upon is that foreign chemicals effect the brain and body’s ability to 
function efficiently, causing neurological, psychological, and physiological dependence 
(NIDA, 2014). Some people develop an addiction that causes biopsychosocial disruptions 
in their daily life that decreases their quality of life, while others do not (Erickson & 
White, 2009). Attempts at achieving stability without continued abuse of the chemical is 
often challenging and involves chronic relapses (NIDA, 2014).  
Genetics 
Susceptibility to foreign chemicals may have very little to do with learned 
behavior and more to do with genetics (Levran et al., 2009). Genetics might play a 
significant role in one’s susceptibility to dependence (Nielsen et al., 2008). All people 
have genetic variances associated with classes of drugs such as opiates or specific genetic 
heritability such as alcoholism (Kreek et al., 2005). For example, genetic researchers 
45 
 
discovered a propensity for alcoholism is due to receptor genes that correlate with 
dependent behaviors (Buckland, 2008). Levran et al. (2009) examined the genetic 
influence of heroin. They agreed heroin dependence, much like alcoholism, has a genetic 
component which contributes to patients being susceptible to ongoing drug use and 
chronic relapses.  
Nielsen et al. (2008) suggested genetics might also provide a level of control 
when resisting addictive behaviors. Two-thirds of patients who started using opiates do 
not become addicted because of their genetic predispositions. However, approximately 
one-third of those who tried using opiates developed an immediate psychological and 
physiological dependence (Levran et al., 2009; Nielsen et al., 2008; Vohs & Baumeister, 
2009). Their usage lead to the development of addictive behaviors and resulted in a 
diagnosis of substance use disorders (Levran et al., 2009; Nielsen et al., 2008; Vohs & 
Baumeister, 2009). 
While gender and exposure to stress factors into a person’s drug use, adding 
sensitization, vulnerability and genetic influences could increase the risk for addiction 
(Berridge & Robinson, 2016). Vohs and Baumeister (2009) concur and reported there is a 
need to factor in people’s genetic makeup and neurological vulnerabilities, which could 
play a role in addiction and the propensity for multiple addictions. Berridge and Robinson 
(2016) reported, research in this area demonstrated the brain’s sensitivity to drugs effects 
neurons like the dopamine, glutamate and mesolimbic neurons, and drug abuse effect 
neurotransmitters. For example, the shape of the mesolimbic neuron and the number of 
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dendritic spines could be altered. This causes a hyperreactive response to environmental 
triggers associated with a foreign chemical, reinforcing a person’s need to obtain the 
primary drug more salient. Berridge and Robinson (2016) also reported individual 
vulnerabilities, such as genetics, gender, sex hormones, and major stressors are factors 
contributing to ongoing drug use for some people. A combination of these factors places 
a person at a higher risk for sensitization and potential substance use disorder.  
Environmental Influences 
The chronological sequence of the development of an addictive disorder begins 
with reinforcement of internal or external triggers (Gifford and Humphreys, 2005). As the 
person takes actions, such as seeking out and using drugs, the continued use of foreign 
chemicals turns into abuse and loss of control (Gifford & Humphreys 2005). When loss 
of control becomes apparent, it is due to the reinforcement of an acute neurological 
response to the foreign chemical causing euphoria (Gifford & Humphreys 2005). 
Heidbreder (2008) suggested this positive reward of euphoria initiates further drug-
seeking behavior and impulsivity.  
Kreek et al. (2005) thought the greatest risk factors for developing an addiction 
would surface during adolescence and young adulthood. In the United States, there was 
an increase in illegal drug use of 1.7% from 2008 to 2011 among young adults 
(Cabriales, Cooper, & Taylor, 2013). Young adults who make up 13.2% of the population 
also represented the highest percentage, 32%, of illegal prescription use (Cabriales et al., 
2013). Carlson and Larkin (2009) discussed how addiction occurs because of young 
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peoples’ inability to cognitively manage or behaviorally adjust to internal or external 
events that tax their coping ability. They further suggested addiction might affect people 
of all ages when stress is the catalyst (Carlson & Larkin, 2009). Cyders et al. (2007) and 
Whiteside and Lynam (2001) believed understanding the genesis of addiction begins with 
understanding the personality traits of an individual. However, they do not know the 
exact way personality contribute to developing addictions.  
Neurobiology 
The accumulated body of research indicated substance use disorders are the result 
of neurobiological reactions at a cellular level where molecules create structural changes 
and shifts in behavior (Heidbreder & Newman, 2010). Using a foreign chemical presents 
the potential for altering the brain’s executive functioning, thereby affecting people’s 
ability to control decision-making along with short and long-term memory (Heidbreder & 
Newman, 2010; NIDA, 2014). 
Researchers further explained that tolerance of a foreign chemical is the body’s 
way of seeking the initial effect experienced upon introduction of the chemical 
(Heidbreder & Newman, 2010). As time passes, the person needs more of the chemical to 
reach a desired euphoric state (Heidbreder & Newman, 2010). In other words, reaching 
tolerance required increasing the dose to maintain initial effects of the drug (Scimeca, 
Savage, Portenoy, & Lowinson, 2000). Neurological dependence is the result of the body 
building up a tolerance for a foreign chemical causing withdrawal syndromes with 
sudden cessation (Heidbreder & Newman, 2010).  
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Addiction is a complex neurological disease. Neural circuits in the brain send out 
different types of neurotransmitters that move from one area of the brain to others 
reinforcing addictive behaviors (Karim & Chaudhri, 2012). The dopaminergic system 
releases different neurons to the serotonergic, mesocorticolimbic, and endogenous opioid 
systems (Karim & Chaudhri, 2012; Leeman & Potenza, 2013; Neto & True, 2011; 
Niehaus et al., 2009). The main region of the brain responsible for reinforcing addictive 
behaviors is the mesolimbic reward system where primitive drives make people 
instinctively seek out food, shelter, and sex (Karim & Chaudhri, 2012). All drugs activate 
reward systems, but the mesocorticolimbic system is most important to understanding the 
reward circuit and addictive drives. It consists of two areas, the mesolimbic and the 
mesocortical pathways (Leeman & Potenza, 2013). 
The ventral tegmental transmits the dopamine through the nucleus accumbens, 
also known as the mesolimbic pathway, and from the ventral tegmental to the prefrontal 
cortex, also known as the mesocortical pathway (Leeman & Potenza, 2013; Niehaus et 
al., 2009). Karim and Chaudhri (2012) included the endogenous opioid systems with the 
dopaminergic system as most influential to reinforcing additive behaviors through reward 
activation. Dopaminergic neurons activate reward circuitry in the brain located in the 
amygdala, the prefrontal cortex, the hippocampus, and frontal cortex regions (Leeman & 
Potenza, 2013; Neto & True, 2011).  
Serotonin is a monoamine neurotransmitter, which travels through serotonergic 
pathways located in the ventral tegmental area of the brain the prefrontal cortex and the 
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amygdala (Neto & True, 2011; Niehaus et al., 2009). The serotonergic system releases 
low levels of serotonin increasing levels of risky behaviors (Neto & True, 2011). In 
contrast, the dopaminergic system releases elevated levels of dopamine, creating reward-
seeking behavior (Neto & True, 2011). Leeman (2013) reported either high or low level 
of dopamine could lead to impulsive, risk-taking behaviors. Impulsivity, a characteristic 
of addictive disorders, render people helpless in the face of impetuous behaviors that the 
brain’s reward system reinforces (Whiteside & Lynam, 2001). The reinforcement causes 
an uncontrollable urge or strong motivation to seek out drugs, thereby causing a lack of 
control over addictive behaviors associated with substance use disorders (Neto & True, 
2011). 
Heidbreder (2008) suggested dopamine was responsible for emotions and 
people’s cognitive ability to function. The researcher further asserted that dopamine was 
the culprit responsible for ongoing activities associated with substance use disorders 
(Heidbreder, 2008). The nucleus accumbens produce two main dopamine sub-type 
neurons: dopamine D1 and dopamine D2 (Levran et al., 2009). Dopamine travels to the 
ventral tegmental area, then onward to the nucleus accumbens, the olfactory tubercle, and 
then the ventral striatum (Levran et al., 2009). The mesocortical and mesolimbic tract is 
the second passage from the ventral tegmental to the cortex (Littrell, 2010; Nielsen et al., 
2008). These tracks work together in releasing dopamine throughout the brain, 
reinforcing positive and negative response to initiating addictive behaviors associated 
with substance use disorders (Littrell, 2010; Nielsen et al., 2008). Scientists have not 
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fully understood the expression of neuron receptors of dopamine D1 and dopamine D2, 
or how the nucleus accumbens mediates their interaction to reduce sensations of reward 
(Levran et al., 2009). 
Researchers focused on specific areas of the brain that help the addiction industry 
understand the development of substance use disorders. For example, Schmitz (2005) 
indicated the nucleus accumbens are where three types of opioid receptors are located 
and are responsible for hedonic responses, Mu, Delta, and Kappa receptors. These 
receptors react to signals delivered from the central nervous system where three opioid 
systems called the Beta-endorphin, the enkephalins, and the dynorphins produce hedonic 
responses that initiate rewards or cravings (Levran et al., 2009; Schmitz, 2005).  
There are other sections of the brain influenced by emotional stimuli. Nielsen et 
al. (2008) suggested the amygdala draws attention to emotional stimuli, such as stress or 
grief, thereby stimulating sensory input. This activation influences the orbitofrontal 
cortex, which modulates emotions. Nielsen et al. (2008) further explained both amygdala 
and the orbitofrontal cortex appear to influence each other through the stimulation of 
neurons. The orbitofrontal cortex receives information from the amygdala and indirectly 
from the amygdala through the anterior cingulate cortex. Nielsen et al. (2008) also 
suggested the prefrontal cortex is part of the brain responsible for executive functions, 
including self-control. Frontal lobes affect substance use disorders by causing acute 
effects to chronic dysfunctions (Nielsen et al., 2008).  
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Bornovalova et al. (2005) and Haile, Kosten, and Kosten (2008) discovered the 
introduction of stimulants into the reward circuitry dopamine partially blocks antagonists 
as they produce euphoria. Researchers determined that stimulants could interfere with 
perceptual motor speed and cause neuropsychological inhibition, impair behavior, as well 
as neuroanatomical abnormalities affecting concentration, memory loss, and the inability 
to learn information. Karim and Chaudhri (2012) suggested both chemical and behavioral 
addiction stimuli affect the neurological pathways. They further suggested 
overstimulation such as triggers in the environment has the potential of altering the 
reward circuitry and could cause repetitive behaviors that are out of one’s control. Karim 
and Chaudhri (2012) called repetitive behaviors, addictive behaviors. Addictive 
behaviors are maladaptive behaviors responsible for the lack of control over actions and 
ability to think rationally regardless of negative consequences (DEA, 2013; Gifford & 
Humphreys, 2007; Grant et al., 2010; Sheffer et al., 2012). 
As cases of substance use disorders increased, it was important to understand the 
underlying neurobiological mechanism and the neuro-adaptation of addictive behaviors 
associated with relapses. First, substance use disorders and the accompanied addictive 
behaviors influence neurobiological functioning (Buckland, 2008; Gifford & Humphreys, 
2007; Grant et al., 2010; Kreek et al., 2005). Second, personality traits play a significant 
role in how a person reacts to their internal and external triggers (Cyders et al., 2007; 
Whiteside & Lynam, 2001). Finally, operant conditioning and negative reinforcement 
create a chronic cycle of repetitive behaviors each time a person experiences a stimulus in 
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the environment (Lefcourt, 1966; Rotter, 1975; Schmitz, 2005). Most importantly, Karim 
and Chaudhri (2012) concluded, any stimuli which alter the reward circuitry and causes 
repetitive behaviors could lead to addictive disorders.  
Psychological and Physiological Dependence 
Gifford and Humphreys (2007), and Grant et al. (2010) found the most pertinent 
indicator of being physically dependent on a foreign chemical is when the absence of the 
foreign chemical produces withdrawal symptoms. Withdrawal syndromes manifest as 
physiological and psychological reactions that cause discomfort. Physical dependence is 
the result of the body physiologically adapting to the introduction of the drug into the 
body’s system on a regular basis (Gifford & Humphreys, 2007; Grant et al., 2010). To 
alleviate withdrawal, the person progressively needs to use more of the foreign chemical 
for symptoms to subside (Gifford & Humphreys, 2007; Grant et al., 2010).  
Other signs a chemical dependence has developed are when a person becomes 
aware of the length of time in which the use of a drug occurs and the increased need to 
use more of the drug (Gifford & Humphreys, 2007; Grant et al., 2010). Gifford and 
Humphreys (2007), and Grant et al. (2010), further agreed that additional signs of 
neurological dependence and the development of an addiction include the time and 
energy consumed in seeking out, finding, using, and recovering from the use of the 
chemical. 
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Gender and Substance Use Disorder 
In the field of addiction, conflicting ideology of treating all men and women as 
equal, compared to addressing gender-specific needs, was a dilemma for some treatment 
programs because men and women are different biopsychosocially (Lev-Ran, Le Strat, 
Imtiaz, Rehm, & Le Foll, 2013; Samuelsson, 2015). Researchers suggested there are 
gender differences when examining alcohol, prescription drug, and illegal drug abusers 
(Shannon, Jackson, Perkins, & Neal, 2014). This was consistent when examining patterns 
of drug use, dependence, prevalence, and specific attributes (Lev-Ran et al., 2013; 
Samuelsson, 2015). Green (2006) reported there was no relationship between gender and 
admittance to treatment. However, the researcher reported women tend to seek treatment 
earlier in their addiction cycle than men (Green, 2006).  
Traditionally, when practitioners applied interventions through the lens of 
stereotypical masculinity and femininity roles, they placed men and women at equal risk 
of missing appropriate treatment (Samuelsson, 2015). They did not take “gender into 
account by acknowledging the different experiences, expectations, pressures, inequalities, 
and needs of women, men, transgender, and intersex people” (Samuelsson, 2015, p. 189), 
as well as cultural factors (Lev-Ran et al., 2013). 
The United States population of men was 49% in 2014, while women represented 
51%, documenting there were more women than men in the United States (SAMHSA, 
2016c). In 2012, there were approximately 23.1 million people in the United States who 
needed treatment for substance use disorders, but only 2.5 million sought medical 
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attention (Yeom, 2015). In 2011, SAMHSA (2013b) reported 112,978 women were in 
opioid treatment programs compared to 161,688 men. This continued to be a statistical 
pattern. A longitudinal study conducted by SAMHSA (2016c) revealed more men entered 
treatment than women with 68% admission rate in 2004 compared to 66% in 2014. These 
statistics indicated a disproportionate number of men sought treatment in contrast to 
women (SAMHSA, 2016c). 
Women. Across the United States, women represented 541,914 (34%) admissions 
out of 1,614,358 admissions into treatment programs. Within this population, the average 
age for women who used some form of stimulant was 33 years old for Methamphetamine 
and 44 years old for cocaine (SAMHSA, 2016d). The average age for narcotic use was 34 
years old for heroin and 33 years old for opiates (SAMHSA, 2016d). SAMHSA (2016d) 
reported in 2014 women in California represented 57,781 (36%) admissions into treatment 
programs, out of a total of 158,434. Among the admissions in California, 21,084 reported 
Methamphetamines were the primary drug, 11,959 reported heroin was the primary drug, 
4,074 reported opiates were the primary drug, and 2007 reported crack cocaine or cocaine 
were the primary drug (SAMHSA, 2016d).  
When women entered treatment, they tended to report more serious 
biopsychosocial problems and physiological health issues (Choi, Adams, Morse, & 
MacMaster, 2015; Green, 2006; McNeese-Smith et al., 2009; Nelson-Zlupko, Fauffman, 
& Dore, 1995). Although both men and women had similar drug use patterns, substance 
use disorders had a greater effect on women’s mental health (Green, 2006). Women 
presented with severe psychiatric scores and higher rates of mental health disorders 
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(Mahmood, Vaughn, Mancini, & Fu, 2013; McNeese-Smith et al., 2009). They also had a 
higher rate of physical issues (Mahmood et al., 2013; Shannon et al., 2014). Shannon et 
al. (2014) conducted a study examining substance users who were in prison and reported 
almost twice the number of women with a substance use disorder had a higher rate of 
mental health problems than men with substance use disorder. Women suffered from 
major depressive disorder, anxiety disorders (Kang & Deren, 2009; Shannon et al. 2014), 
and borderline personality disorder, compared to men who suffered from antisocial 
personality disorder (Shannon et al., 2014).  
When examining medical utilization among women who used drugs, women met 
with more barriers than men. Kang and Deren (2009) reported, compared to men who had 
the Human Immunodeficiency Virus and were actively using drugs, women who actively 
used drugs and had the Human Immunodeficiency Virus tended to neglect their health by 
delaying treatment or experienced difficulty with getting treatment. They also 
experienced more symptoms associated with the Human Immunodeficiency Virus and 
experienced more side effects from the medication. Women also experienced sexual and 
physical abuse more than men, which were factors that kept women from utilizing 
healthcare services (Kang & Deren, 2009). 
Women used drugs with their significant other (Kang & Deren, 2009), but did not 
use drugs as much as men and did not have as many drug related problems (Choi, et al., 
2015; Green, 2006; McNeese-Smith et al., 2009). However, women were more 
susceptible to substance addictions and developed substance use disorders faster than 
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men (Green, 2006; McNeese-Smith et al., 2009). Women abused specific prescription 
drugs such as narcotic analgesics and tranquilizers due to mental health issues and for 
managing physical pain (Shannon et al., 2014). Lev-Ran et al. (2013) conducted a study 
examining gender differences in prevalence rates of substance use disorders among 11 
substances: heroin, cocaine, cannabis, nicotine, alcohol, hallucinogens, inhalants 
sedatives, tranquilizers, opioids, and amphetamines. The study indicated women had a 
low lifetime prevalence for all the substances mentioned above. However, historical 
trends indicated women used, abused, and became dependent on prescription 
medications. Lev-Ran et al. (2013) also reported socio-cultural stigmas related to drug 
dependence might have been a factor in women limiting or avoiding heavy drug use. 
When examining stigma associated with substance abuse, Hatgis et al. (2008) 
reported society does not hold women accountable for making poor judgments and 
viewed them as “victims of their circumstances” (p. 189). According to these authors, the 
women’s degree of responsibility for problems related to alcohol and other drugs 
depended on the type of substance they misused. Haseltine (2000) argued the opposite, 
stating women who used alcohol and other drugs faced more criticism due to lack of 
family support, low socioeconomic status, and mental health disorders.  
Historically, women performed poorly in alcohol and other drugs treatment 
programs when evaluating the lack of treatment success and low retention rates (Nelson-
Zlupko et al., 1995). Prior treatment for women correlated with them having a mental 
health disorder, providers not referring them to treatment, and fewer voluntary 
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admissions (Haseltine, 2000). Typically, treatment programs for women centered on 
gender norms based on society’s definition of femininity and biases that women need 
more help with medical and mental health assistance (Samuelsson, 2015).  
Because of the shame and stigma associated with substance use disorders, women 
hesitate to seek treatment, resulting in experiencing higher levels of severity 
(Samuelsson, 2015). However, when women do take advantage of treatment they 
gravitate towards outpatient services (Choi et al., 2015; Yeom, 2015). When in treatment, 
women were actively engaged in the counseling process and used the services provided 
to them (Choi et al., 2015). They also seemed to benefit more from single-gender groups 
(Choi et al., 2015). Haseltine (2000) reported practitioners should have an awareness that 
women are internal thinkers and tend to self-medicate as a coping mechanism more than 
men do. Haseltine (2000) further stated women display more emotionality and are at 
greater risk of committing suicide. 
Women face more barriers when seeking treatment (Green, 2006; McNeese-Smith 
et al., 2009). For example, women contend with a lack of childcare and lack of 
employment (Green, 2006; Mahmood, 2013; Shannon et al., 2014). Women have 
difficulty coping with their histories of physical or sexual abuse, poverty, and instability 
with housing, mental health issues, along with shame when seeking treatment (Mahmood, 
2013; McNeese-Smith et al., 2009; Samuelsson, 2015; Shannon et al., 2014). Even with 
these barriers, women who completed treatment remained abstinent longer than women 
who did not complete treatment (Green, 2006).  
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Haseltine (2000) reported women experience repetitive cycles of relapse from 
treatment while facing the stigma characterized by the public as addicts. To understand 
why relapses continued to occur, researchers explored the brains' biochemistry. They 
found women’s brain are organized different from men. For example, when interpreting 
word patterns, women use their left inferior frontal gyrus and their right hemisphere 
homolog to perform the same function as men. 
To sustain treatment retention, some programs implemented therapeutic alliance 
models which focused on person-centered care, gender specific interventions, inclusion in 
treatment, and a host of other biopsychosocial interventions (Choi et al., 2015). 
Regardless of the services provided, reasons for retention success among women varied 
depending on the study (McNeese-Smith et al., 2009). Studies conducted by Green 
(2006) and McNeese-Smith et al. (2009) suggested retention success is due to women 
having fewer problems associated with their drug use and with mental health issues. 
Income and the ability to pay for services due to insurance coverage were additional 
factors (McNeese-Smith et al., 2009). McNeese-Smith et al. (2009) indicated predictors 
of retention success included the woman’s single marital status, not being African 
American, or unemployed. Choi et al. (2015) agreed employment and higher incomes 
increased the possibility of success. A third study indicated legal referrals for treatment 
added to positive retention rates. Overall, both women and men had consistent treatment 
success when comparing retention rates, percentages of treatment completion, and long-
term outcomes (McNeese-Smith et al., 2009). However, women tended to remain 
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abstinent longer, and relapsing increased when exposed to substance abusing romantic 
partners or when they experienced overwhelming personal problems (McNeese-Smith et 
al., 2009).  
Mahmood et al. (2013) reported 69% of women in prison had substance use 
disorders diagnoses and had a higher rate of substance dependence than male prisoners. 
Mahmood et al. (2013) further reported from 1977 to 2007 the population of women in 
prison grew by eight hundred and thirty-two. Researchers indicated no differences in 
recidivism based on gender (Chen, 2009; Mahmood et al., 2013). Chen (2009) reported 
women abused drugs more than men during their incarceration, which made substance 
abuse an ongoing concern in prisons. Over 80% began abusing drugs within six months 
of returning to prison and 65% abused cocaine (Chen, 2009). Women who did not abuse 
drugs while incarcerated attributed their abstinence to lower coherence, greater levels of 
anxiety, and a higher potential for becoming victims of sexual assault (Chen, 2009). 
Minority women experienced greater vulnerability as they represented 70% of the prison 
population (Chen, 2009).  
When focusing on treatment interventions, traditionally, women receive more 
attention than their male counterparts (Samuelsson et al., 2015). Researchers examining 
treatment outcomes in prison indicated gender played a significant role in achieving 
success (Shannon et al., 2014). Chen (2009) posted a need for “separate gender-oriented 
therapeutic interventions” (p.255). Mahmood et al. (2013) reported starting treatment in 
prison should transition into their lives upon their release. However, traditional treatment 
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approaches such as residential programs and community-based programs have not been 
successful for this population once they completed their period of incarceration 
(Mahmood et al., 2013). Their utilization of services is a strong predictor of whether they 
will have successful outcomes (Shannon et al., 2014; Yeom, 2015). Choi et al. (2015) 
reported completion of drug court programs assisted with women in decreasing the 
likelihood of relapse.  
There are commonalities among gender that influenced outcomes, such as the 
person’s age, primary drug, the level of education, employment status, and criminal 
history (Shannon et al., 2014). Mahmood et al. (2013) suggested treatment programs 
should focus on peer relationships among women with similar backgrounds. However, 
Green (2006) reported treatment programs that focused on specific genders bared similar 
outcomes as those serving both genders. Green (2006) suggested identifying triggers and 
outcomes throughout the treatment process. Brief low-cost interventions demonstrated 
positive outcomes for women (McNeese-Smith et al., 2009). Examples include 
interventions providing computer literacy and case management services for women on 
welfare (McNeese-Smith et al., 2009). Shannon et al. (2014) reported programs focusing 
on strengthening family relations, attending to medical issues and mental health concerns, 
along with drug abuse, resulted in positive post-treatment outcomes. 
Men. In the United States, men represented 1,072,049 (66%) admissions out of 
1,614,358 admissions into treatment programs (SAMHSA, 2016d). Among this population, 
the average age for men who used some form of stimulant was 33 years old for 
Methamphetamine and 44 years old for cocaine (SAMHSA, 2016d). The average age for 
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narcotic use was 34 years old for heroin and 33 years old for opiates (SAMHSA, 2016d). In 
2014, men in California represented 100,567 (64%) admissions out of 158,434 admissions 
into treatment programs (SAMHSA, 2016d). Among these men, 27,214 reported 
Methamphetamines were the primary drug, 26,311 reported heroin was the primary drug, 
4390 reported opiates were the primary drug, and 4365 reported crack cocaine or cocaine 
were the primary drug. Shannon et al. (2014) indicated age was a predictor for reduced 
recidivism. Men abused narcotics more than women and had an 11% higher rate of abusing 
illegal and legal drugs than women (Samuelsson, 2015; Shannon et al., 2014).  
As referred to earlier, the Lev-Ran et al. (2013) study examined gender 
differences in the prevalence of substance use disorders among 11 substances: heroin, 
cocaine, cannabis, nicotine, alcohol, hallucinogens, inhalants sedatives, tranquilizers, 
opioids, and amphetamines. They found cannabis was the most commonly abused 
substance in male populations while heroin was the least abused (Lev-Ran et al., 2013). 
The researchers indicated men had a higher lifetime prevalence for all the substances 
included in the study. Men suffered from substance use disorders more than women and 
demonstrated higher rates of substance use disorders from prescription drugs (Lev-ran et 
al., 2013; Steingrimsson, Carlsen, Sigfusson, & Magnusson, 2012). Although men were 
less likely to abuse prescription drugs, the prevalence of prescription drug use that 
developed into a substance use disorder was higher for men (Lev-Ran et al., 2013; 
Nelson-Zlupko et al., 1995). 
Haseltine (2000) revealed men experienced repetitive cycles of relapse from 
treatment while facing the stigma characterized by the public as addicts. To understand 
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patterns of behavior and why relapses continued to occur, researchers explored the brains' 
biochemistry. They reported men’s brain organization interpreted word patterns by using 
more of their left inferior frontal gyrus, similar to women.  
Hatgis et al. (2008) reported when considering gender differences; people held 
men more accountable for making poor judgments. Haseltine (2000) argued the opposite. 
He stated men do not face as much criticism as women. Problems for males was related 
to the type of alcohol or substance used. 
When examining the lack of treatment success and low retention rates, historically 
men performed better than women in alcohol and other drugs treatment programs 
(Nelson-Zlupko et al., 1995). Pressure from family and social institutions seemed to be 
what caused men to initiate a search for treatment (Haseltine, 2000). When men entered 
treatment, the focus was on employment and education, not trauma (Samuelsson et al., 
2015). Employed Caucasian men had better attendance and longer retention rates. 
Additionally, having an adequate income and medical insurance to pay for treatment had 
a positive correlation with high retention rates for men (McNeese-Smith et al., 2009).  
A factor predicting success with retention for men was age. Researchers 
documented the older the man, the better success they had with staying in treatment 
(McNeese-Smith et al., 2009). Men referred by their employer also reported positive 
retention rates (McNeese-Smith et al., 2009). Most importantly, having goals associated 
with abstinence increased retention success for men (Choi et al., 2015). Choi et al. (2015) 
reported men’s length of stay in treatment programs predicted lower rates of substance 
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use once out of treatment, along with decreased recidivism rates. Choi et al. (2015) also 
reported men who left treatment before completion experienced unfavorable treatment 
outcomes.  
Primary drug use co-occurring with a mental health diagnosis proved to be a 
predictor of shorter retention rates for those who abused cocaine (Choi et al., 2015). 
However, men’s problems stemming from substance abuse were less problematic than 
those experienced by women (Samuelsson et al., 2015). Practitioners should understand 
that men are external thinkers, social, and used drugs as a form of exploration (Haseltine, 
2000). Shannon et al. (2014) found men were more active in criminal activities and 
committed their first crime 10.4 years younger than women did. However, when 
comparing recidivism rates, there was no differences based on gender (Chen, 2009). 
When examining the rate of drugs used among men in prison, Mahmood et al. (2013) 
reported men abused drugs at a higher rate than women. However, Chen (2009) indicated 
men remained abstinent for longer periods due to higher coherence, lower anxiety levels, 
and less hostile feelings. When men exited the legal system, they returned within two 
years (Shannon et al., 2014).  
Chen (2009) posited the need for “separate gender-oriented therapeutic 
interventions” (p. 255). However, treatment programs focused on specific genders 
resulted in similar outcomes compared to treatment programs that serve both genders 
(Green, 2006). Shannon et al. (2014) reported significant success with post-treatment 
outcomes for both genders across treatment modalities. As a result, Green (2006) 
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suggested the focus should be on a need for treatment providers to focus on identifying 
triggers throughout the duration of services. Regardless of gender, there were several 
factors requiring attention when considering the need for positive outcomes, such as the 
person’s employment status, primary drug, the level of education, and criminal history 
(McNeeses-Smith et al., 2009; Shannon et al., 2014). Practitioners should assure clients 
establish a goal of abstinence while receiving services (McNeese-Smith at al., 2009).  
In conclusion, practitioners should be aware of the differences between genders 
when treating substance use disorders. Women are more likely to abuse licit drugs while 
men are more likely to abuse illicit drugs (Nelson-Zlupko et al., 1995). Practitioners 
should also apply various types of treatment interventions for each patient, taking into 
account their biopsychosocial needs that include age, ethnicity, gender, life experiences, 
trauma, and treatment history that would influence attrition rates (Samuelsson et al., 
2015). Researchers demonstrated treatment services pathologize women’s substance 
abuse and dependence while underestimating the needs of men (Samuelsson et al., 2015). 
Practitioners should be mindful of their personal biases and prejudices which marginalize 
and stigmatize men and women (Samuelsson et al., 2015). 
Treatments for Substance Use Disorders 
Mennis et al. (2012) reported 205 million people worldwide abused drugs in 
2012, of which 35% to 85% did not receive treatment. The National Survey of Substance 
Abuse Treatment Services revealed from 2008 to 2012, 23.9 million Americans used 
illegal drugs, 9.2% of the total population (Cummins et al., 2009; Stanforth et al., 2016). 
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SAMHSA (2016b) examined opiate abuse in 2014. The report revealed 4.8 million 
Americans used heroin at least once that year and 4.3 million Americans abused 
prescription opioids or opiates. Banta-Green, Maynard, Koepsell, Wells, and Donovan 
(2009) documented the availability of prescription opioids resulted in an increased 
number of admissions into treatment programs across the United States from 0.9% to 
4.2% in 2006. Baird (2015) reported the Division of Pharmacological Therapy oversees 
1250 opiate treatment programs in the United States who provided services to 
approximately 300,000 patients each year. Providers anticipated a need for increased 
services would continue to rise as the number of reported abusers of prescription opioids 
increased. 
The Center for Behavioral Health Statistic and Quality (2015) reported 1.6 million 
Americans abused prescription stimulants, of which 569,000, or one-third were 
homemade Methamphetamines. SAMHSA (2013a) indicated 947,000 people were 
dependent on or abused illegal drugs, but only 117,000 received treatment. In 2014, 
SAMHSA’s (2016c) longitudinal study spanning from 2004 to 2014 reported 1,614,358 
admissions for five primary drugs, 36% to treat alcohol abuse, 30% for opiates and heroin 
abuse, 15% marijuana abuse, 15% Methamphetamine and amphetamine abuse, and 5% 
for cocaine and crack cocaine abuse. 
There are four types of treatment programs that address substance use disorders. 
SAMHSA (2016c) listed them as: Ambulatory, an outpatient treatment service that 
includes individual or group treatment and pharmacological therapy. This category also 
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includes intense outpatient treatment requiring two or more hours of treatment per day for 
at least three or more days per week. Detoxification could include 24-hour treatment in a 
residential facility or a hospital. This category also includes ambulatory outpatient 
treatment with or without pharmacological therapy. Rehabilitation includes residential 
short-term (30 days or less) or long-term (more than 30 days), or rehabilitation in the 
hospital for 24 hours. Medication-assisted opioid therapy consists of pharmacological 
therapy (methadone or buprenorphine) provided in an outpatient setting that could be 
intensive outpatient or detoxification program in a residential facility, hospital or 
ambulatory. Treatment could be administered during residential short or long-term 
programs or inpatient hospital treatment. 
SAMHSA (2016c) conducted a longitudinal study in the United States spanning 
from 2004 to 2014. There were 1,614,358 admissions into treatment programs for alcohol 
abuse, opiate and heroin abuse, marijuana abuse, Methamphetamine and amphetamine 
abuse, and cocaine and crack cocaine abuse. SAMHSA (2016c) also reported opiates 
increased from 3% in 2004 to 8% in 2014. Opiate as the primary drug represented 19% of 
opiate admissions in 2004 and 27% in 2014. In 2014, men represented 53% of admissions 
for opiate treatment with an average age of 33 years old. Eighty-four percent of those 
admitted into treatment in 2014 were White. The primary route of use for 60% of those 
reporting opiate abuse used oral methods, and 17% reported inhalation as their route of 
choice.  
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SAMHSA (2016c) reported, admission into treatment for heroin abuse increased 
by 36% from 262,518 admissions in 2004 to 357,293 admissions in 2014. This 
represented an increase from 15% in 2004 to 22% in 2014 (SAMHSA, 2016c). Heroin as 
a primary drug represented 81% of the opiate admission in 2004 but decreased to 73% in 
2014 with the average age at 34 years old. Two-thirds of heroin users were males, 69% 
were White, 14% were Hispanic, and 12 % were Black. The preferred routes of use were 
injection at 72% and inhalation at 22% (SAMHSA, 2016c).  
SAMHSA (2016c) also reported, during 2004 cocaine admissions decreased from 
14% to 5% in 2014. Crack cocaine as the primary drug represented 72% of cocaine 
admission in 2004 and 66% in 2014. The average age of crack cocaine users was 44 years 
old, and the average age for cocaine users was 38 years old. Of the total number of 
people who used crack cocaine, Blacks represented 56%, Whites at 32%, and Hispanics 
eight percent. Cocaine users consisted of 34% Blacks, 43% Whites, and 19% Hispanic. 
Inhalation was the primary route of use for 79%, while 11% preferred injection.  
SAMHSA (2013a) reported during the year 2012, there were 1,611 treatment 
facilities in California, which offered opiate treatment programs, and 125,756 patients 
received treatment. A study conducted by SAMHSA (2015) indicated of the 158,435 
Californians who received treatment for substance use disorders, 46,754 were for 
narcotics abuse, and 54,756 were for stimulants abuse. SAMHSA (2015) reported the 
increase of treatment facilities appeared to have had a significant impact.  
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As indicated above, in the United States men entered treatment more than women 
(SAMHSA, 2016c). For example, in California a disproportionate number of men entered 
treatment at a higher rate than women (SAMHSA, 2016d). SAMHSA (2016d) reported 
California had 158,434 admissions in 2014 for substance use disorders, which included 
100,567 admissions initiated by men and 57,781 admissions initiated by women. When 
examining primary drug and gender, men represented 26,311 admissions into treatment 
for heroin compared to 11,959 admissions by women. Opiate admissions were about 
equal with 4,390 admissions initiated by men and 4,074 admissions initiated by women. 
Men had a slight edge with Methamphetamine and amphetamine admissions with 27,214 
treatment attempts compared to 21,084 treatment attempts by women. For crack cocaine, 
men were responsible for 3,163 admissions while women represented 1,670 admissions. 
Cocaine also indicated men seeking treatment more often with 1,202 admissions 
compared to 337 admissions initiated by women. Therefore, a need exists for alternative 
treatment approaches to attract and retain women in treatment (Nelson-Zlupko et al., 
1995). 
Retention in treatment programs was a growing concern and a focus for Banta-
Green et al. (2009) as they examined whether people who choose prescription opioids as 
their primary drug stayed in treatment longer than people who choose heroin. Banta-
Green et al. (2009) demonstrated that people who abused prescription opiates had better 
retention rates than heroin abusers, due to fewer health problems and better social 
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stability. However, heroin users in methadone treatment programs tend to do better in 
treatment with adequate doses of methadone (Bao et al., 2009).  
Treatment Approaches 
Addictive behaviors encompass a constellation of maladaptive behaviors due to 
people’s inability to self-regulate or control impulses when faced with internal and 
external stimuli, despite consequences of acting on these impulses (Grant et al., 2010; 
Rotter, 1966; Sheffer et al., 2012; Webb et al., 2010). In the addiction field, the question 
as to what type of treatment intervention works (12 step programs or empirically based 
techniques; such as harm reduction and biopsychosocial methods) is secondary to 
understanding the patient and the disorder (Bristow-Braitman, 1995).  
Opiate and Opioid drug abuse is, “a major health and social burden” (Bao et al., 
2009, p. 28). In 2000, there were 179,000 patients enrolled in methadone maintenance 
treatment programs in the United States (Scimeca et al., 2000). Methadone maintenance 
treatment programs provide methadone to patients with opioid and opiate dependence to 
prevent withdrawal (Bao et al., 2009). Bao et al. (2009) reported higher doses of 
methadone correlate with high retention rates, while high dropout rates are due to low 
doses of methadone. Banta-Green et al. (2009) reported treatment availability for 
prescription opiate users increased in the United States from 0.9% to 4.2% in 2006 and 
was anticipated to continue to rise as the need for treatment increased with the escalating 
rates of prescription abuse.  
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Banta-Green et al. (2009) emphasized how essential it is for effective treatment to 
be available for this growing population. Most concerning for Banta-Green et al. (2009) 
were the retention rates in treatment programs across modalities. Hall (2001) also 
expressed concern about retention rates among people diagnosed with substance use 
disorders. Hall (2001) hoped the administration of the DRLOC scale would help increase 
these rates across treatment modalities. Banta-Green et al. (2009) focused on the type of 
drug used to gain an understanding of retention rates among narcotic abusers. Banta-
Green et al. (2009) found patients who used prescription opiate as their primary drug 
stayed in treatment longer than patients who used heroin as their primary drug. 
Furthermore, there were better retention rates for patients with a history of prescription 
opiates than with a history of heroin due to fewer health problems and better social 
stability (Banta-Green et al., 2009).  
Practitioners and researchers continued to discover methods to treat addiction. 
From traditional treatment approaches, such as harm reduction (Rosenberg & Phillips, 
2003), to the latest innovative approach to treatment, such as immunotherapy (Zalewska-
Kaszubska, 2015), the field of addiction continues to change as counseling techniques 
and medical approaches show a significant difference in patient’s quality of life. 
Therefore, it is necessary to assess a person’s readiness to change behaviors associated 
with their primary drug and measurement of meaningful change in their Quality of life 
(Hall, 2001; Pasareanu et al., 2015). Lubman et al. (2004) indicated change is not easy 
and requires the belief that change could occur. It also requires motivation that drives a 
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person toward changing maladaptive behaviors and discipline to maintain a level of 
control over the impulsivity that feeds addictive behaviors (Lubman et al., 2004).  
Patient-Centered Care. Davidson et al. (2008), as well as other researchers, such 
as Larkin et al. (2006), encouraged individuals, organizations, and the healthcare field to 
demonstrate a positive shift in how they treat patients with addictions. They encouraged 
practitioners in medical and mental health settings to become more person-centered, 
compared to focusing on a patient’s diagnosis or disorder. Person-centered or client-
centered care allows for individualized treatment plans and research approaches.  
Rogers (1992) introduced the original concept of patient-centered or client-
centered care as a theory. The theory consisted of six components: Recognizing there is 
an interaction between the two parties; patients and practitioners. Recognizing the 
presence of incongruence, meaning how the patient views his experience compared to the 
actual experience. The practitioner’s acceptance and awareness of self and staying true 
and genuine to who he is as an individual. The practitioner’s unconditional acceptance of 
the patient, meaning acceptance and caring for the patient as an individual. The 
practitioner’s ability to have and express empathy, meaning meeting the patient where he 
is in his understanding of self and the experience that brought him into treatment. The 
patient’s perception of the practitioner, meaning the patient awareness of the 
practitioner’s acceptance of the patient and his situation and the empathy the practitioner 
presents.  
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According to Kirschenbaum and Jourdan (2005), over the years since the 
introduction of Rogers’ theory of patient-centered care, researchers have narrowed these 
six elements down to three main components, “empathy, unconditional positive regard, 
and positively congruent” (p. 37). Incorporating the patient-centered approach across 
mental health and addiction settings could help diminish the underlining stigma 
associated with substance use disorders. This individualized approach to treatment aligns 
with individualized assessments. Along with cognitive behavioral therapy techniques, 
motivational interviewing, and several other evidence-based strategies, an individualized 
assessment helps practitioners learn more about the patient to develop a rapport that is 
supportive and less punitive (NIDA, 2008).  
Conceptual Framework 
Rotter (1966) explained the way people react to a situation or event depends on 
how much control they believe they have over the situation or event and their 
expectations of the outcomes. Rotter (1966) further explained the person’s past helps to 
determine whether they experienced positive or negative reactions to current, similar 
experiences. Because of past experiences, the person expects similar outcomes in the 
future (Rotter, 1966). Rotter (1966) termed this generalized expectancy. To measure 
generalized expectancy and how much control people feel they have over current 
situations or events, Rotter and Mulry (1965) developed the Internal-External Locus of 
control (I-E LOC) scale. The I-E LOC scale was a unidimensional tool that provided a 
generalized assessment of LOC.  
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Over the years, researchers modified the I-E LOC scale from a unidimensional 
generalized instrument for measuring people’s response to life’s experiences to a 
multidimensional instrument targeting specific domains or topic of interest. For example, 
Keller and Blomann (2008) modified versions of the generalized I-E LOC scale to 
measure skills demand in the workforce and the health status of veterans (Marshall et 
al.,1990). In the field of addiction, Keyson and Janda (1972) modified the I-E LOC scale 
to address alcoholism by developing the Drinking Related Internal-External (DRIE) 
scale. Hall (2001) further modified the DRIE scale to develop an individualized 
instrument called the DRLOC scale, which addresses substance abuse. 
Hall’s LOC Study  
Rotter (1966) developed generalized expectancy theory and the I-E LOC 
construct. The I-E LOC scale did prove useful in the area of addiction for some 
researchers. Researchers examined the relationship between LOC and narcotics, LOC and 
alcohol, and LOC and alcohol and other drugs (Berzins & Ross 1973; Calicchia, 1974; 
Cox & Luhrs, 1978; Rotter, 1966). Researchers addressed the limitations of the I-E LOC 
scale as a unidimensional instrument and its inability to transition from an individualist to 
a collectivist culture (Lefcourt, Von Baeyer, Ware, & Cox, 1979; Marshall et al., 1990; 
Smith et al., 1995). Hall (2001) concurred with the critics of the I-E LOC scale and set 
out to develop a domain-specific, individualized instrument to measure LOC (Bright, 
Kane, March, & Bishop, 2013; Hattrup, O’Connell, & Labrador, 2005; Lefcourt, 1992; 
Smith et al., 1995). 
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Keyson and Janda (1972) explored the concept of LOC related to alcohol abuse to 
develop the DRIE scale. The researchers translated the I-E LOC scale from a 
measurement of expectancy in the general population to an instrument that would 
measure expectancies of an individual (Davis et al., 2014; Keyson & Janda, 1972). There 
have been numerous studies examining the relationship between alcohol usage and LOC, 
but little research exists related to substance abuse and LOC (Hall, 2001). Hall (2001) 
wanted to explore how people with substance use disorders make decisions related to 
drug use and the concerns directly related to substance abuse, such as the relationship 
between self-esteem and low retention rates in treatment programs. To get a more 
accurate measurement of LOC in the substance use disorder population, Hall (2001) 
modified the DRIE instrument by changing the words on the DRIE associated with 
alcohol to words related to drugs. Hall (2001) called the new LOC instrument the 
DRLOC scale for assessing LOC in patients with substance use disorders. Hall (2001) 
argued an individualized assessment of LOC compared to a generalized assessment of 
LOC could provide a better predictor of treatment outcomes in men and women 
diagnosed with substance use disorders. 
Hall (2001) and Davis et al. (2014) identified the DRIE scale as one of the first 
internal-external instruments modified from Rotter’s original generalized I-E LOC scale, 
to measure a specific factor in the field of addiction. The DRIE scale measured people’s 
perception of how much control they have over their behaviors associated with drinking 
alcohol and the recovery process (Davis et al., 2014). In 1978, Donovan and O’Leary 
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conducted a study to measure the reliability of the DRIE scale (Davis et al., 2014). 
Compared to other control-oriented instruments, the DRIE showed a significant 
correlation supporting the validity of the instrument and demonstrated “high-level test 
reliability alpha and Kuder-Richardson coefficients of internal consistency of .77” (Davis 
et al., 2014, p. 875). Research conducted using the DRIE scale demonstrated scores that 
discriminate between people who identify as being dependent on substances and those 
who identify as non-dependent on substances (Davis et al., 2014). Furthermore, 
measurements from the DRIE scale have proven to predict substance use behaviors after 
treatment (Davis et al., 2014).  
The DRIE consists of 25 items and is a forced-choice instrument, with a score of 
two representing an external-LOC and a score of one representing an internal-LOC (Hall, 
2001; Davis et al., 2014). With forced-choice instruments, participants must choose 
between two sets of statements presented to determine which more closely represents 
their belief system or behavior (Davis et al., 2014). 
Hall (2001) modified the DRIE scale to measure expectations related to substance 
abuse. The goal was to transform the DRIE scale into a shorter version associated with 
drug use. To do this, Hall examined the analysis of the DRIE scale generated by Donovan 
and O’Leary in 1978. Hall selected 15 items from the DRIE instrument with high-factor 
loading and adjusted the questions by changing words related to alcohol with words 
related to drugs to create a forced-choice, internal-external instrument. Hall called the 
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instrument the DRLOC scale. The purpose of the DRLOC scale was to identify belief 
systems related to primary drug use by measuring expectancies related to drug use. 
Hall’s (2001) DRLOC scale (Appendix B) includes statements that measure drug 
use expectancies in drug-related situations to determine LOC. Forced choice items give 
two statements per item forcing the participant to choose one of the two statements. An 
example of a forced-choice item with two statements is item number six on the DRLOC; 
successfully kicking substance abuse is a matter of demanding work.  The two statements 
presented are, A) luck has little or nothing to do with it, and B) staying clean depends 
mainly on things going right for you. Item A equal one point and item B equal 2 points. 
After the participant completes the instrument, the interviewer adds the numbers circled 
by the participant and divides the sum by 15 (the total number of items on the scale) to 
get the mean score. A score that is closer to one represents a more internally controlled 
locus, and a score that is closer to two indicate a more external locus. People with an 
internal-LOC score are more likely to be actively engaged, alert, and spontaneous people, 
trying to achieve their goals. They quickly and emotionally adjust with stronger 
interpersonal skills, actively seeks information, has a higher sense of self, and can make 
decisions independently. People identified as having an external-LOC score are more 
prone to be more depressed, have anxiety, and have limited abilities to cope with daily 
stressors. 
After an exhaustive literature search, I found Ersche et al. (2012) was the most 
recent study using the DRLOC. Ersche et al. (2012) did a factor analysis of the DRLOC 
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scale by comparing it to Rotter’s and Mulry’s (1965) I-E LOC scale. Their study 
consisted of 592 volunteers, of which 282 were receiving treatment for narcotics, 
stimulants, or alcohol, while 310 reported no drug history and identified themselves as 
professionals and nonprofessionals. Among the participants of both groups, age and 
ethnicity did not vary significantly. However, gender was slightly different with 46% of 
men and 54% of females participating in the control group with no history of drug use 
represented. The percentage of men in the group with a history of drug use was 75% 
while women represented 25%. 
The DRLOC scale has proven to be an appropriate instrument that could benefit 
patients and practitioners (Escher et al., 2012). Many studies have demonstrated one’s 
LOC orientation shifts during the therapeutic process (Page & Scalora, 2004). Page and 
Scalora (2004) suggested that practitioners measure LOC from an external to internal 
shift while in treatment. The score thus becomes an indicator that the assigned 
interventions were a viable treatment strategy. Therefore, measuring shifts in LOC would 
help patients and practitioners develop appropriate interventions throughout the recovery 
process (Scimeca et al., 2000). 
Researchers stated those who are diagnosed with substance use disorders are so 
because of their chronic relapsing patterns of behaviors. People who are diagnosed with 
substance use disorder continued to use regardless of the consequences to their health or 
productivity (Davidson et al., 2008; Gifford & Humphreys, 2007; Grant et al., 2010; 
Vohs & Baumeister, 2009). Examining one’s cognitive processes related to substance 
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abuse is important to understanding multiple relapses and appropriate treatment. Ersche 
et al. (2012) explained that the DRLOC scale could effectively measure people’s 
perception of impulse control over addictive behaviors. Ersche et al.’s (2012) study 
demonstrated a reliability of the DRLOC instrument at .81 for measuring thought 
processes. Therefore, utilizing the DRLOC scale during treatment could help 
practitioners understand patients thought processes related to their drug use, thereby 
helping practitioners develop appropriate interventions to meet the patient’s individual 
needs (Ersche et al., 2012).  
Internal-External Locus of Control Scale 
The conceptualization for LOC consists of a bipolar construct spanning the 
spectrum from internal control to external control. People with an internal-LOC have an 
awareness and acceptance of positive or negative consequences resulting from their 
behaviors, while people with an external-LOC attribute achievements or lack of success 
to actions out of their control (Page & Scalora, 2004).  
Some of the studies with the I-E Control scale explored task structure and I-E 
Control (Lefcourt, 1966). In 1955, one study examined interpersonal variables and I-E 
Control (Lefcourt, 1966). During 1959 to 1965, researchers explored the I-E Control and 
conformity and from 1960 to 1965 additional studies explored risk-taking and I-E Control 
(Lefcourt, 1966). The I-E Control research showed the construct of control or one’s 
perceived control would be very useful in understanding behavior (Lefcourt, 1966). In 
fact, during the first 30 years of its conception, the construct of I-E Control and 
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expectancy were the most cited topics in the psychology and social science field with 
4700 citations in Monograph since the first expository paper written by Rotter, Seeman, 
and Liverant in 1962 (Rotter, 1990). 
Rotter and Mulry (1965) continued to research the I-E Control scale by 
administering the scale to college students (N = 120). There were 61 women, and 59 men 
participated in the studies as part of the entry-level psychology course. Researchers 
randomly assigned participates in two groups: an internal group (skill group), and an 
external group (chance group). The external group was the control group. The experiment 
consisted of angle matching tests of problems designed to be difficult. The researchers 
informed one-half of the sample group that the choices would be extremely difficult and 
would require luck to achieve the goal of discriminating. The other half of the sample 
group was informed that prior studies showed their choice might be difficult but with 
skill, one could achieve the goal of discriminating. 
Two researchers conducted the study and asked the participants if they felt they 
would be successful in getting the trail correct during the next trail on a scale of 0 to 10. 
The researchers administered the I-E Control scale to half the participants before 
conducting the main experiment, and then after the main experiment administered the I-E 
Control scale to the other participants. The researchers did not score the results of the 
instruments. Instead, they took the participants and alternately placed them in either the 
change group or the skill group.  
80 
 
The second part of the study consisted of two procedures. One training consisted 
of eight trials. During these trials, all participants received equal reinforcements and then 
informed of being correct 75% of the time. The second part consisted of interviewers 
informing participants during the second and the fourth trials that they made wrong 
choices. Afterward, the final stage of the study included the extinction phase consisting 
of 50 consecutive trials. During this part of the experiment, each participant was told they 
were wrong everytime. If participants responded with 0 or 1 to the likelihood they would 
get the next trail correct, the study for that person ended.  
The study resulted in an average score of 8.48 for the I-E Control scale, and a 
medium score of 8.0. The researchers identified mean scores nine or more as external 
thinkers and people who scored eight or less as internal thinkers. The overall result of the 
study concluded that participants instructed with chance discrimination resulted in 29 
internal thinkers and 19 external thinkers. Participants instructed with skills 
discrimination resulted in 36 internal thinkers and 26 external thinkers. Rotter and Mulry 
(1965) indicated the results showed no significant difference between men and women. 
Informing internal thinkers that the tasks required skills slowed their decision-making 
process. External thinkers took longer to decide when told luck or chance was the 
determining factor. 
As a result of this study, the I-E Control scale was renamed the I-E LOC scale and 
then published in 1965 by Rotter and Mulry. The goal of Rotter and Mulry was to find a 
more specific way of predicting reinforcement’s influence on expectancies. The intent 
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was to have a low correlation with other scales used to measure behaviors (Rotter, 1966). 
Most importantly, the I-E LOC scale predicts and gauges behaviors across a broad range 
of potential situations and disciplines, and with no expectations of high internal 
consistency (Smith et al., 1995).  
Over the years, researchers in the psychology and social science fields extensively 
studied the I-E LOC constructs with a focus on individualizing domains instead of 
limiting the scope to general topics (Hall, 2001; Page & Scalora, 2004). For example, 
researchers viewed the I-E LOC scale as a unidimensional instrument with a narrow 
scope of questions on several topics, of which drew lots of criticism. From this criticism, 
researchers started to modify the I-E LOC scale by creating a multidimensional 
instrument that provides broader questions for a specific topic (Hattrup et al., 2005; 
Lefcourt, 1992; Smith et al., 1995). Examples of some topics included happiness 
(Pannells & Claxton, 2008), anger and impulsivity (Deming & Lochman, 2008), 
communication (Lam & Mizerski, 2005), conscientiousness (Hattrup et al., 2005), Health 
(Marshall et al., 1990) productivity in the workplace and job performance (Forte, 2005; 
Smith et al., 1995). 
Rotter (1966) further emphasized people who accepted their history of repeated 
failures due to events out of their control, could obtain a sense of control over what 
happens to them in the future. On the other hand, the researcher also explained, people 
who feel they have total control of their life, learn, in the face of adversity, there are 
things they cannot control.  
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Because of internal and external factors that influence people’s behaviors, Bright 
et al. (2013) supported an individualized instrument and suggested a LOC instrument 
focused on a specified area would be more useful than a global instrument that covers 
multiple domains. Hall’s (2001) DRLOC scale is an example of an individualized, 
multidimensional instrument, which focused on one domain, substance use disorders, and 
has demonstrated high capabilities for predicting outcomes compared to a generalized, 
unidimensional instrument like the I-E LOC scale (Ersche et al., 2012). 
Summary 
Addiction is best defined as being a brain disorder or neurological disease caused 
by molecular changes in the brain’s chemistry due to foreign chemicals introduced into 
the system (Caan, 2012). Addictive Behaviors encompass a constellation of maladaptive 
behaviors forcing patients to lose control over their actions and their ability to think 
rationally regardless of negative consequences (DEA, 2013; Gifford & Humphreys, 2007; 
Grant et al., 2010; Sheffer et al., 2012). Mennis et al. (2012) reported 205 million people 
worldwide abused drugs in 2012, of which 35% to 85% did not receive treatment. The 
National Survey of Substance Abuse Treatment Services revealed from 2008 to 2012, 
23.9 million Americans used illegal drugs, 9.2% of the total population (Stanforth et al., 
2016; Cummins et al., 2009). According to reports in California, approximately 876,000 
Californians used and abused illicit drugs in 2014 (SAMHSA, 2015a). 
The newest paths scientists and researchers take explores the influence of 
addictive behaviors by examining neurobiology and genetic variations (Davidson et al., 
83 
 
2008; NIDA, 2014). They seek to understand the brain’s dysfunctions and how the brain 
influences compulsive and impulsive patterns of addictive behaviors (Lubman et al., 
2004).  
In the field of addiction treatment, there are four main types of treatment 
modalities: ambulatory, detoxification, rehabilitation therapy, and medication-assisted 
opioid (SAMHSA, 2016c). The question as to what type of treatment intervention works 
is secondary to understanding the patient and the disorder (Bristow-Braitman, 1995). 
Recognizing the role gender has in substance use disorders is important when deciding 
interventions. Nelson-Zlupko et al. (1995) reported on the differences between genders 
related to chemical addictions. Haseltine (2000) reported men used drugs as a form of 
exploration while women tend to self-medicate as a coping mechanism. Haseltine (2000) 
further reported women are internal thinkers and are more likely to abuse licit drugs 
while men are more external thinkers and are more likely to abuse illicit drugs. 
It is necessary to assess a person’s readiness to change behaviors associated with 
their primary drug and measure significant changes in their quality of life (Hall, 2001; 
Pasareanu et al., 2015). Incorporating a person-centered approach to addiction treatment 
could help diminish the underlining stigma associated with substance use disorders and 
bring more people into treatment (Davidson et al., 2008; Kirschenbaum & Jourdan, 2005; 
Larkin et al., 2006). Providing an individualized approach to treatment aligns with the 
implementation of individualized pre and post assessments (Foon, 1986; Hall, 2001). Pre 
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and post assessments help measure progress in treatment and success with individualized 
interventions and could assist in the development of future services (Foon, 1986).  
One tool that could help measure progress in treatment is the DRLOC scale. 
According to Rotter (1966), LOC refers to people’s perception of control based on past 
experiences and internal or external reinforcement in the environment. When applied to 
addiction and addictive behaviors, the amount of control or lack of control they had over 
the outcome of a similar event determined the patients’ level of expectancy for positive or 
negative reinforcements (Rotter, 1966). Hall (2001) argued an individualized assessment 
of LOC compared to a generalized assessment of LOC could result in a better predictor 
of treatment outcomes (Rotter, 1966). As a result, Hall (2001) developed the DRLOC 
scale for assessing LOC in patients with substance use disorders.  
The goal of this pre-experimental, quantitative study was to explore the potential 
relationship between LOC and primary drug use among men and women who had been 
diagnosed with a substance use disorders. I utilized secondary data from a study 
conducted by Hall (2001) titled, Feelings About Drug Use, Drug-Related Locus of 
Control, that examined men and women diagnosed with a substance use disorder by 
administering the DRLOC instrument. The methodological choices, as well as procedures 
I used to collect and analyze this data is detailed in chapter 3. 
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Chapter 3: Research Methodology 
The purpose of conducting this study was to closely examine some of the data 
generated by Hall’s DRLOC study. Hall developed and administered the DRLOC scale, 
which is an individualized assessment tool that measures LOC in patients diagnosed with 
substance use disorders. In this chapter, I provided a detailed description of Hall’s 
DRLOC study and the UCLAs Integrated Substance Abuse Programs’ original study 
titled Drug Treatment Process and Drug Treatment Counselor Practices and 
Effectiveness. Participants in the Feelings About Drug Use, DRLOC study were recruited 
from the Drug Treatment Process and Drug Treatment Counselor Practices and 
Effectiveness study. I examined the recruitment process, threats to validity, ethical 
procedures, methodology, and data analysis related to Hall’s Feelings About Drug Use, 
DRLOC study. 
Research Design and Rationale 
The current study is a quantitative preexperimental static group comparison 
design using secondary data from research conducted by Hall to examine the effect 
gender and primary drug use has on DRLOC scores. Hall’s investigation was part of a 
larger study conducted by the UCLAs Integrated Substance Abuse Programs’, Drug 
Treatment Process and Drug Treatment Counselor Practices and Effectiveness study. The 
UCLAs study included 666 participants from 19 treatment programs. In addition to 
alcohol, there were responses from people who abused ten types of drugs. They were 
amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, 
86 
 
methaqualone, opiates, phencyclidine, and propoxyphene (Hall, 2001). Hall (2001) 
conducted a follow-up study using 553 of the original 666 participants.  
Hall (2001) dealt with whether there was a relationship between LOC scores and 
self-esteem in people with substance use disorders and whether the DRLOC scale 
outcomes related to retention rates in treatment programs. This current study examined 
DRLOC scores by extracting from Hall’s 553 participants a sample size of men and 
women who identified narcotics or stimulants as the primary drug for which they were 
being treated.  
Using the data generated by the UCLAs Integrated Substance Abuse Programs as 
secondary data provided an existing structure for proceeding with examining the three 
variables presented for the current study. Hall (2001) reported the original study 
conducted by the UCLAs Integrated Substance Abuse Programs examined the process 
associated with drug treatment and counseling practices, along with their effectiveness in 
relation to drug treatment. Hall (2001) examined the usefulness of identifying LOC and 
self-esteem as it related to substance abuse. The current study builds on the understanding 
gained from these two previous studies by examining the effect gender and primary drug 
had on the DRLOC score.  
Methodology 
Population  
I conducted the current study using secondary data generated by the UCLAs 
Integrated Substance Abuse Programs’ Drug Treatment Process and Drug Treatment 
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Counselor Practices and Effectiveness study. The sample size in the UCLAs study was 
666 participants diagnosed with substance use disorders from 19 drug treatment 
programs. From the UCLAs Integrated Substance Abuse Programs’ study, 553 
participants agreed to participate in Hall’s (2001) Feelings About Drug Use, DRLOC 
study.Hall reported among the participants there was a mean age of 36.2 (SD = 9.58), a 
mean year of education of 12.2 (SD = 2.47), and a median household income of $10,000-
14,999. There were more females (n = 300, 54.2%) than males (n = 253, 45.8%), and the 
majority of participants were either Caucasian (n = 227, 41.1%), African-American (n = 
178, 32.2%), or Latino (n = 103, 18.6%).  
Original Study’s Procedures for Recruitment  
According to Hall (2001), the UCLAs study recruited participants from 19 drug 
treatment programs in Los Angeles County representing five different treatment 
modalities: Inpatient and outpatient treatment, residential, day treatment, and methadone 
programs. The researchers assured the representative programs reflected proportionately 
with each treatment model within Los Angeles County. Each program’s number of 
participants proportionally represented the population within their respectful treatment 
modality. They randomly selected participants from large programs to assure 30 
participants per program. For smaller programs, the staff selected patients to participate, 
including new admissions, until they obtained 30 participants. Variations existed among 
the programs related to time in treatment and philosophy. 
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Of the 666 participants in the University of California Los Angeles study, 101 
participants refused to participate in Hall’s (2001) DRLOC study. Additionally, Hall’s 
final sample only included those with 12 or more non-missing responses across the 15 
DRLOC items, resulting in a final sample of 553 participants. Trained interviewers 
conducted the meetings with each participant. The requirements for participation in the 
DRLOC study included being in treatment for at least two weeks. The University of 
California Los Angeles Integrated Substance Abuse Programs granted permission for 
participants recruited from detoxifications programs to participate for 3 to 5 days after 
admission into their program. The interviewers held the meetings in private rooms 
located at each treatment facility. The interviews lasted approximately 45 minutes, and 
each participant received $10 for their participation and $5 for contributing a urine 
sample. 
Permission to Use Archival Data  
The procedure required to obtain approval to use the UCLAs Integrated Substance 
Abuse Programs’ data from the Drug Treatment Process and Drug Treatment Counselors 
Practices and Effectiveness study, and the Feelings About Drug Use DRLOC study, 
consisted of contacting Hall via email with a formal request to use the data from the 
Feelings About Drug Use, DRLOC study. Hall provided required documents needing 
signature and information from the researcher, the Chair, and representatives of Walden 
University’s Institutional Review Board (IRB). Additionally, I obtained approval from 
Walden’s IRB by signing the data use agreement to assure proper use of the data. I 
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secured all the letters and emails to and from Dr. Hall and official documents in a locked 
file in my home office (see Appendix A).  
Archival Data Sampling Procedure  
Eligible participants from Hall’s data consisted of those with non-missing data on 
DRLOC, primary drug, and gender. A filter was created so that only eligible participants 
were included in analyses. Hall did not report there was any missing data regarding 
DRLOC or gender, so exclusions were based on those whose primary drug was not a 
narcotic or stimulant. According to Hall’s codebook, there were three other primary drug 
categories: alcohol, marijuana, and other. Hall did not report proportions by primary 
drug; however, Spear, Crevecoeur, Rawson, and Clark (2007) reported that 56.6% of 
treatment admissions in Los Angeles County between 2001 and 2005 were for narcotic or 
stimulant drugs and the remaining 43.4% were for alcohol, marijuana, or other drugs. 
Therefore, it was reasonable to expect that of Hall’s 553 participants, half or more were 
likely to be eligible for the proposed secondary analyses. Based on a sample size of 402, 
a G*Power sensitivity power analysis calculates a 2x2 full factorial ANOVA would 
detect as statistically significant (p < .05) a small partial η2 = .02 (Cohen’s f = .13) for a 
main effect or interaction.  
Instrumentation and Operationalization of Constructs 
 Hall (2001) developed a LOC instrument called the DRLOC scale modified from 
the DRIE scale, which addressed LOC and alcohol. Hall modified the DRIE instrument 
by changing the words associated with alcohol to words associated with drugs to develop 
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the DRLOC scale. Hall administered the DRLOC scale in a secondary study to 
participants who had participated in the Drug Treatment Process and Drug Treatment 
Counselor Practices and Effectiveness study conducted by UCLAs Integrated Substance 
Abuse Programs (Hall, 2001). The goal of the second study, titled Feelings About Drug 
Use, DRLOC, was to measure drug-related LOC in patients receiving treatment for 
substance use disorders (Hall, 2001).  
The DRLOC scale was the latest LOC instrument in the field of social science, 
spanning over 70 years. Hall analysis of the DRLOC instrument found α = .81. Hall 
measured internal consistency by applying Cronbach’s alpha and the split-half procedure 
using the Spearman-Brown Prophecy formula. Hall explained the Feelings About Drug 
Use, DRLOC study was large and hindered the procedure for test-retest reliability and 
examined other measures to test convergent validity by examining correlations of scores. 
This included participant’s DRLOC score and Addiction Severity Index scores which 
positively correlated (r = .301 p <.00). This demonstrated that high scores generated from 
the Addiction Severity Test (except for the subscale, Medical) correlated with a high 
score from the DRLOC (external-LOC). It should be noted that of the seven domains on 
the Addiction Severity Index scale (medical, employment, alcohol and drugs, legal, 
family and social relationships, and psychiatric) the subscale of alcohol and drugs 
demonstrated the highest correlations with a score of .283.  
Hall (2001) reported the results from the DRLOC study indicated men’s LOC 
scores were higher than women (p < .01). Mean scores among ethnic groups indicated 
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Latino’s scores were significantly high with LOC mean at 1.34, (p < .01). Hall also 
reported there was no significant difference in LOC among age groups. However, there 
was a significant difference between participants across treatment modality at p < .01. 
Hall discussed how participants from hospital inpatient treatment programs had the 
highest mean at 1.51 compared to participants from outpatient drug-free programs with 
the lowest mean at 1.19. The DRLOC scale positively correlated with the Addiction 
Severity Index at .301, which indicated that as addiction severity increased, scores on the 
DRLOC tend to increase toward external-LOC values.   
 For this study, , the DRLOC scale functioned as the dependent variable. The score 
obtained from the DRLOC scale served to measure the differences among men and 
women who used narcotics versus stimulants. The DRLOC scale consists of 15 forced 
choice items that give two statements for each item forcing the participant to choose one 
of the two statements identified as A or  B. Statement A equal one point and statement B 
equal 2 points. The 15 items measure LOC on a continuum from internal to external. 
After the participant complete the DRLOC scale, the interviewer adds the numbers 
circled by the participant. The numbers circled for items 1, 3, 5, 8, 11, 14, and 15 must be 
reverse coded. After recoding, the DRLOC score is computed simply by taking the mean 
score of all the items. The total score is then divided by 15 (the total number of items on 
the scale) to get the mean score. A score that is closer to one represents a more internally 
controlled locus, and a score that is closer to two indicate a more externally controlled 
locus.  
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 As applied to this study, people with a score closer to one is considered to have an 
awareness and acceptance of positive or negative consequences resulting from their drug 
use, while people with a score closer to two is considered to attribute positive or negative 
consequences from drug use as actions out of their control. E. A. Hall (personal 
communication, June 20, 2016) identified the variable named “flocscor” in the archival 
SPSS data set as the 15-item composite mean representing DRLOC scores. Scores from 
participants who identified narcotic or stimulants as their drug use at the time of 
treatment are included in the sample population and analysis.   
 Drug use, as defined in this study are narcotics and stimulants, and served as the 
independent variable that represented the two categories. This study examined the extent 
by which DRLOC scores differ with narcotic use versus stimulant use. Hall’s research 
identified seven categories for drug use in her study, of which alcohol, marijuana, and the 
category, other, was excluded from my sample and analysis. Hall listed narcotics as a 
self-contained category and in her codebook assigned code 7. The categories that consists 
of cocaine, crack, amphetamine and Methamphetamine were recoded into a single 
category to represent stimulant.  
 The second independent variable in this study was gender. As represented in 
Hall’s study and listed on the initial intake form, gender comprised of two levels, male 
and female. The archival SPSS data set had this variable coded as follows: male = 1, 
female = 2. The importance of examining gender in this study was to determine if a class 
of drugs being used by men versus women impacted DRLOC scores.   
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 Demographics for Hall’s DRLOC study was obtained from participants and 
coded. Some of Hall’s demographics: race, education, and socioeconomic status, were 
included in this study as a covariate in the primary analysis. Not addressed in Hall’s data 
set was information on age. This study included age by calculating the difference 
between 1996 (which was the intake interview year) and the year of birth, which was on 
the demographic questionnaire. The number obtained would represent the age of the 
participant at the time of treatment intake.  
 In Hall’s study, participants were asked to identify self by race. Hall provided a 
list of seven options with assigned codes: White = 1, Black or African-American = 2, 
Asian or Pacific Islander = 3, Native American = 4, Hispanic = 5, Multi-racial = 6, and 
other = 7. In the archival SPSS data set the variable is f1q13 and its label. “race”.  
 Hall’s question about education was how many years of schooling the participant 
completed. As noted in Hall’s codebook, the question was labeled “# years school 
completed” and could be found in the archival SPSS dataset named flq16. 
 An important demographic obtained from Hall’s study and evaluated as part of 
this study was socioeconomic status. As part of Hall’s archival SPSS data set 
socioeconomic status named f1q23 and labeled “your 95 income range”. The range 
documented in the codebook was list as under $19,000 to over $200,000. Within this 
range, participants were given 19 categories to choices from.  
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Research Question, Hypotheses, and Analysis Plan 
The dependent variable was DRLOC scores, in which a low score indicates an 
internal-LOC and a high score indicates an external-LOC. The independent variables 
were primary drug (narcotic or stimulant) and gender (male or female). Of primary 
interest was the effect of the primary drug on DRLOC score, but because Hall (2001) 
found males had statistically significant higher DRLOC scores than females, it was 
important to control for gender and examine any interaction effect between gender and 
primary drug. To simplify the hypotheses that followed, the test of a specific effect 
assumed statistical control for the other effects. 
RQ1: To what extent do DRLOC scores differ by primary drug (narcotic vs. 
stimulant), gender (male vs. female), and their interaction? 
N01: There is no statistically significant difference (p > .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.  
Na1: There is a statistically significant difference (p < .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.   
N02: There is no statistically significant difference (p > .05) in DRLOC scores 
between males and females.  
Na2: There is a statistically significant difference (p < .05) in DRLOC scores 
between males and females.  
N03: There is no statistically significant interaction effect (p > .05) between 
primary drug and gender on DRLOC scores.  
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Na3: There is a statistically significant interaction effect (p < .05) between 
primary drug and gender on DRLOC scores. 
To test the hypotheses and answer the research question, a 2x2 full factorial 
ANOVA was conducted. This helped to simultaneously test the main effect of the 
primary drug, the main effect of gender, and the interaction effect. If any of the other 
study variables—age, race, socioeconomic status, or education—is found to relate to 
DRLOC scores, it was entered as a covariate in the primary analysis. 
Threats to Validity 
 Hall’s sample population for the DRLOC study was recruited from the previous 
study conducted by the UCLAs Integrated Substance Abuse Programs. A threat to 
external validity could occur from participant’s knowledge of moving from one study to 
another with researchers they are familiar with. Because of this knowledge participants’ 
reaction to topics presented might influence behavior because of familiarity. An 
extraneous variable is the potential the participant is under the influence of stimulants or 
narcotics. Active drug use could influence behavior and thought processes, thereby 
effects the responses to the DRLOC scale. 
Selection bias could be another threat to internal validity due to the five stages of 
change and motivation associated with the process of recovery and addictive behaviors 
(DiClemente, 2003; Norcross et al., 2011; Prochaska & Norcross, 2001). The five stages 
of change demonstrate the level of awareness a participant has about their addictive 
behaviors, and how this awareness influences their recovery (DiClemente, 2003; 
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Norcross et al., 2011; Prochaska & Norcross, 2001). According to the theory of stages of 
change, those who chose to participate in the study are more likely to fall in the later 
stages of change compared to the first two stages of change (DiClemente, 2003; Norcross 
et al., 2011; Prochaska & Norcross, 2001). The effect this could have on the study is 
significant if the majority of participants are in the later stage of recovery.  
Furthermore, the phenomenon of participants giving a socially appropriate 
response compared to honest responses representative of their addictive behaviors and 
thought processes could affect internal validity. According to Davis et al. (2014), self-
report instruments tend to move people to respond in a way that is contrary to how they 
might respond if the possibility of tracking their answers existed. Davis et al. (2014) 
reported the need to present oneself in a favorable way, to make a positive impression, or 
to exaggerate responses to feeling socially acceptable are all concerns when 
administering self-report instruments like the DRLOC scale. Davis et al. (2014) further 
reported what is most important when using a self-report instrument to measure treatment 
success in people with substance use disorders is the need to stay aware of a person’s 
reason for treatment, as well as their need for social desirability (Davis et al., 2014). 
Ethical Procedures 
The UCLAs Integrated Substance Abuse Programs, Dr. Hall, the researcher of the 
Feelings About Drug Use, DRLOC study, the Chair over the current study, and a 
representative of Walden University’s Center for Research Quality, Institutional Review 
Board agreed the need for reviewing ethical procedures for securing the dataset. The 
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procedure included securing the data during its use and not sharing or using it in an 
unethical way. Furthermore, we agreed I would secure the original copy of the dataset on 
an external drive and stored in a locked safe. The copy used with SPSS program would 
be on a secure desktop that has a secure access code. Finally, I contacted Walden’s 
Center for Research Quality, Institutional Review Board to provide written permission 
through the application process to move forward with obtaining and assuring the security 
of the dataset. Once the study was completed, I would store the dataset for five years. 
Afterward, I would delete the dataset from my hard drive and external drive. I would 
send notification of this action to Dr. Hall, UCLAs Integrated Substance Abuse 
Programs, and Walden’s Center for Research Quality, Institutional Review Board. A 
copy of the permission forms and agreements to use the dataset is in Appendix A. 
Any information that could reasonably identify participants was removed or 
coded if this process had not already been completed in the dataset. This process would 
include removal of participant’s name, geographical location of residence, personal 
information such as telephone numbers, emails, social security numbers, medical record 
numbers, driver license, photos of participants, or any other identifiers that could be used 
to connect the participant with the study. For this study, one identifier was used as the 
date of birth in order to obtain the age of participants at the time the study. Upon 
completion of the study, results of the findings will be written and downloaded onto a 
CD, placed in a sealed envelope, and then forwarded to Dr. Hall by the United States 
Postal Service.  
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Summary 
I conduct a quantitative, pre-experimental static group comparison secondary 
analysis of Hall’s (2001) study, which itself, was a follow-up on a larger study by 
UCLAs Integrated Substance Abuse Programs. From Hall's data set of 553 participants, I 
extract and analysis a subset of 402 participants. The total size of the subset depended on 
the number of participants with non-missing data on the key study variables of DRLOC 
scores, primary drug as either narcotic or stimulant, and gender. The purpose of the 
current study was to examine differences in DRLOC scores between males and females 
and between the two categories of primary drug. The results of this examination are 
presented in Chapter 4. 
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Chapter 4: Research Methodology 
Introduction 
The purpose of conducting this preexperimental quantitative study through 
secondary analysis was to reexamine data on individuals who received treatment for their 
substance use disorders. Specifically, to examine the main factorial effects of primary 
drug (narcotic vs. stimulant), gender (men vs. women), and their interaction on DRLOC 
score. The score generated from the DRLOC instrument is summed and then divided by 
15. A score closer to one represent an internal-LOC, indicating a person is more likely to 
be actively engaged, has a higher sense of self, and can make decisions independently. A 
score closer to two represent an external-LOC, indicating a person more prone to 
depression, anxiety, and a limited ability to cope with daily stressors (Hall, 2001).  
Chapter 4 consists of a description of how the secondary data was obtained as 
well as the results of the statistical analysis. Non-significant and statistically significant 
results of comparisons between the three variables are provided with the use of between 
subject analysis and factorial ANOVA. Reliability of the DRLOC was presented as well 
as screening of targeted demographics for potential covariates. Finally, a summary of the 
results presented in Chapter 5 with an introduction to Chapter 5 is provided.   
Archival Dataset 
 The archival dataset utilized in this study was created by UCLAs Integrated 
Substance Abuse Programs’ Drug Treatment Process and Drug Treatment Counselor 
Practices and Effectiveness study. The sample size in UCLAs study was 666 participants 
100 
 
who were diagnosed with a substance use disorder. The participants were recruited from 
19 drug treatment programs in Los Angeles County. From the UCLAs Integrated 
Substance Abuse Programs’ study, 553 participants agreed to participate in Hall’s (2001) 
Feelings About Drug Use, DRLOC study. Hall’s goal was to measure drug-related LOC 
in patients receiving treatment for substance use disorders. To conduct the current study, 
Hall was contacted with a request to use the data collected from the Feelings About Drug 
Use, DRLOC study. Upon agreement regarding how the data would be used and secured, 
Hall provided the dataset with a codebook for the study. Upon examination of the 553 
participants, a subset of 402 participants who indicated either a narcotic or stimulant as 
their primary drug was identified.  
Variables of Interest 
The focus of the Effect Gender and Narcotic or Stimulant Abuse has on Drug-
Related Locus of Control [DRLOC] (Travis, 2018) study was to determine if primary 
drug use among men versus women affected the DRLOC score. The variables of interest 
were DRLOC scores, primary drugs, and gender. Hall’s code for variables used in the 
main dataset was used for the Effect Gender and Narcotic or Stimulant Abuse has on 
DRLOC (Travis, 2018) study. The code Flocscor represented a 15-item composite score 
from the DRLOC scale (flocq51 to flocq65). For ease of output, Flocscor was renamed 
drloc. The variable that represented main drug treated was coded F1q8 and renamed 
primary drug. Narcotics was recoded as 1. Cocaine, crack, amphetamine, and 
Methamphetamine were combined and coded as 2. All other drug types were recoded as 
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not applicable. The variable Male was coded 1 and female was coded 2. Other variables 
of interest in this study were race, education, income, and age. F1q13 was renamed race, 
f1q16 for education was renamed years of schooling, and f1q23 for income was renamed 
household income to represent socioeconomic status. The dataset did not contain a 
variable for age. Age was calculated by subtracting year of birth (f1q12) from 96 (the 
year the data was collected), to represent age at intake. 
Eligible Cases 
Eligible cases were defined as cases with nonmissing data for drloc, primary drug, 
and gender. Of the cases presented in Hall’s original dataset, 108 were missing drloc 
scores, 34 did not identify a primary drug, and 21 did not provide a gender. There were 
402 cases that had valid data and were eligible for analysis. A filter was created so that all 
subsequent analyses were based only on these 402 cases.  
Descriptive Statistics 
To describe the sample population for this study, the age, race, socioeconomic 
status, and education level of the sample population was reported. Operationalization of 
demographic variables was conducted to determine potential relationship to the DRLOC 
score to be reported as a covariate in the primary analysis. Of the 402 participants in the 
current study, 161 (40%) were male and 241 (60%) were female. Two Hundred and 
Eighty-five (70.9%) participants reported stimulants as their primary drug while 117 
(29.1%) reported using narcotics as their primary drug.  
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Of the 402 participants, 157 (39.1%) were White, 135 (33.6%) were 
Black/African American, 16 (4%) were Asian/Pacific Islander, 5 (1.2%) were Native 
American, 76 (18.9%) were Hispanic, 10 (2.5%) were multiracial, and 2 (.5%) were 
identified as Other. One participant’s data was missing in the system and represented .2% 
of the 402 participants. When examining age, the youngest participant was 19 and the 
oldest participant was 69 (M = 35.46, SD = 8.49). The median was 34. Skewness and 
kurtosis were both less than 1.0 and within acceptable range of normal distribution with 
skewness at .690 and Kurtosis at .731.  
Hall (2001) indicated the education level of those who participated in the study 
averaged 12.2 years. The sample population for this study ranged from a minimum of 6 
years to a maximum of 26 years of education. Years of education had a high kurtosis at 
5.894 because one case reported 26 years; the next closest was 20. The outlier case was 
recoded to 20, which brought the distribution of the variable within acceptable normal 
range with kurtosis at 1.730 and skewness at .678. The normal range was a skewness of 
less than the absolute value of 3 and kurtosis less than the absolute value of 7 (Kline, 
2016). After recoding, the mean was 12.03, standard deviation was 2.25, and the median 
was 12.  
In the case of household income, this variable was coded as range because it was 
an ordinal variable. The means 3.4091 is not itself valid, but it was used to state that the 
average income was between $15,000 and $24,999. The minimum and maximum 
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household incomes were $10,000 to over $200,000, respectively. There were 212 
participants (53.5%) that had household income under $10,000.  
DRLOC Reliability and Descriptive Statistics 
Scores generated from the DRLOC ranged between 1 and 2. People with a score 
closer to one are considered to have an awareness and acceptance of positive or negative 
consequences resulting from their drug use, while people with a score closer to two are 
considered to attribute positive or negative consequences from drug use as actions out of 
their control (Page & Scalora, 2004). Ersche et al. (2012) demonstrated a reliability of the 
DRLOC instrument at .81 for measuring thought processes. For this study, as presented 
in Table 1 and Table 2, the DRLOC had good reliability at .816. Skewness and kurtosis 
were within acceptable range of normal distribution.  
Table 1 
DRLOC Descriptive Statistics 
Statistic Value 
# of items 15 
Cronbach’s alpha .816 
M 1.21 
Median 1.13 
SD .21 
Minimum 1.00 
Maximum 1.93 
Skewness 1.10 
Kurtosis 0.52 
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Inferential Analysis 
The research question examined for this study was: To what extent do DRLOC 
scores differ by primary drug (narcotic vs. stimulant), gender (male vs. female), and their 
interaction? 
N01: There is no statistically significant difference (p > .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.  
Na1: There is a statistically significant difference (p < .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.   
N02: There is no statistically significant difference (p > .05) in DRLOC scores 
between males and females.  
Na2: There is a statistically significant difference (p < .05) in DRLOC scores 
between males and females.  
N03: There is no statistically significant interaction effect (p > .05) between 
primary drug and gender on DRLOC scores.  
Na3: There is a statistically significant interaction effect (p < .05) between 
primary drug and gender on DRLOC scores. 
Screening of Demographics as Covariates or Confounds 
The demographic variables, education level, socioeconomic status, age and race 
were screened as potential covariates or confounds. As a result of the screening, 
education level, socioeconomic status, and age did not demonstrate a direct influence or 
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had an effect on DRLOC scores. Therefore, the demographic variables were not included 
as a covariate in the primary analysis.  
Race was recoded into 4 categories because some of the original categories had 
very small numbers of cases: White, African-American, Hispanic, all other. The “All 
Other” category included Asian/Pacific Islander, Native American, and Multi-racial. 
Levene’s Test of Equality of Error Variances was conducted to test the null hypothesis 
that the error variance of the dependent variable, DRLOC score, was equal across groups. 
Levene’s test was significant, meaning the groups did not have equal variance. However, 
according to Tabachnick and Fidell (2007), if the ratio of the largest group variance to 
that of the smallest group variance is less than 10, than it is okay. In this case the ratio 
was 2.2 (.2482 divided by .1682).  
Analysis of between-subjects presented in Table 2 below, demonstrated DRLOC 
scores do statistically significantly differ by race, F(3, 398) = 7.07, p < .001, eta squared 
= .05 (a medium size effect). Hispanics had higher DRLOC scores than both White and 
African American groups. 
Table 2 
Effect of Race on DRLOC Scores 
  DRLOC  
Race N M SD Homogeneous  
Subsetsa 
White 157 1.22 .22 a 
African-American 135 1.16 .17 a 
Hispanic 76 1.29 .25 b 
All other 34 1.19 .18 a, b 
a Racial categories with the same subset letter did not statistically significantly differ. 
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To further screen for race and its relationship with primary drug, further analysis 
showed there were more African Americans in the stimulant group (n = 121) than 
statistically expected (n = 95.7), and more Hispanics in the narcotic group (n = 42) than 
statistically expected (n = 22.1), χ2(3, N = 402) = 49.51, p < .001, Cramer’s V = .351. 
There were more female African Americans in the study (n = 94) than statistically 
expected (n = 80.9), and more male Hispanics in the study (n = 43) than statistically 
expected (n = 30.4), χ2(3, N = 402) = 14.71, p = .002, Cramer’s V = .191.  
Because race was not independent of primary drug or gender, a preliminary 
factorial ANOVA that included race was performed. There was not a statistically 
significant effect for race, nor race by primary drug 2-way interaction, nor race by gender 
2-way interaction, nor race by primary drug by gender 3-way interaction. Therefore, race 
was not included in the final inferential analysis to test the hypotheses and answer the 
research questions. As noted in Table 12, Levene’s test was significant, but the ratio of 
largest group variance to smallest group variance was within acceptable range to assume 
homogeneity of error variance (.2352 divided by .1652 = 2.04). 
Factorial ANOVA Results 
A 2 (gender) X 2 (primary drug) factorial ANOVA was conducted. Levene’s test 
was significant, but the ratio of largest group variance to smallest group variance was 
within acceptable range to assume homogeneity of error variance (.2352 divided by .1652 
= 2.04). Table 3 shows a between-subject analysis of gender and primary drugs that 
demonstrated the main effect of gender was not significant. Further analysis presented in 
107 
 
Table 4, showed males (1.242) and females (1.276) had relatively equal means on 
DRLOC. The main effect of primary drug was significant and the interaction was 
significant. The narcotic group had higher mean (1.358) for DRLOC scores than the 
stimulant group (1.159). Because the interaction was significant, it is invalid to solely 
rely on the main effects of gender and primary drug to understand differences on DRLOC 
scores. Instead, the focus needed to be on interpreting the interaction. As detailed in 
Table 4, and displayed in Figure 1, females in the narcotic group had higher DRLOC 
scores than males, but females in the stimulant group had lower DRLOC scores than 
males. 
Table 3 
Factorial ANOVA Results of Gender and Primary Drug on DRLOC Scores 
Source SS df MS F p ηp2 
Gender 0.094 1 0.094 2.672 .103 .007 
Primary drug 3.159 1 3.159 89.722 <.001 .184 
Gender*Primary drug 0.380 1 0.380 10.806 .001 .026 
Error 14.013 398 0.035    
Total 17.694 401     
 
Table 4 
DRLOC Scores by Gender and Primary Drug 
 Male Female Total 
Group N M SD N M SD N M SD 
Narcotic 65 1.31 .24 52 1.41 .23 117 1.35 .24 
Stimulant 96 1.18 .16 189 1.14 .17 285 1.15 .17 
Total 161 1.23 .21 241 1.20 .21 402 1.21 .21 
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Figure 1. Interaction effect of gender and primary drug on DRLOC scores. 
Summary 
Archival data of 402 eligible cases were obtained from the UCLAs Integrated 
Substance Abuse Programs’ Drug Treatment Process and Drug Treatment Counselor 
Practices and Effectiveness study. The 15-item DRLOC scale, the dependent variable, 
had a Cronbach’s alpha of .816 and was within normal distribution parameters. Hispanics 
had higher DRLOC scores than Whites and African-Americans. African-Americans were 
overrepresented in the stimulant group and Hispanics were overrepresented in the 
narcotic group. Also, female African-Americans and male Hispanics were 
overrepresented. Despite the confounds around the race variable, a preliminary factorial 
ANOVA of race, gender, and primary drug found no significant main or interaction 
effects involving race, so it was excluded from further analysis. In the factorial ANOVA 
of gender and primary drug on DRLOC scores to test the hypotheses and answer the 
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research question, primary drug and the gender by primary drug interaction effects were 
significant. While, overall, the narcotic group had higher DRLOC scores than the 
stimulant group, the interaction manifested as females in the narcotic group having higher 
DRLOC scores than males, with females in the stimulant group having lower DRLOC 
scores than males. 
Further interpretation and conclusion of the findings, social change implications 
and future considerations of potential implementation of the DRLOC instrument as part 
of the treatment process was discussed in chapter 5. To conclude, the limitations of this 
study and recommendations for future research with the DRLOC instrument were also 
presented in chapter 5.  
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Chapter 5: Discussion 
Purpose Statement 
The purpose of this study was to examine if narcotic or stimulant use among men 
and women effect the DRLOC score and to determine if it is useful to implement the 
DRLOC scale as an individualized instrument to be included in the treatment process. 
Implementing the DRLOC scale at the time of admission, during treatment, and toward 
the end of treatment could potentially help measure several outcomes, including the 
ability to measure patients’ progress in treatment through personal awareness and shifts 
in thought processes and behaviors, or the lack thereof. Additionally, the DRLOC score 
could provide a reasonable understanding of the minimal progress achieved and 
determine the appropriate intervention needed that coincide with the patient’s DRLOC 
score.  
The focus of this study was to examine the effect gender and primary drug had on 
DRLOC. Conducting an extensive literature review, no recent research was discovered 
which focused on LOC and narcotics, LOC and stimulants, or LOC with narcotic and 
stimulants. 
There were limited numbers of assessment tools used for measuring drug-related 
disorders and LOC. The original I-E LOC scale measured individuals’ beliefs in whether 
they could control their consumption of alcohol and did not focus on drug abuse (Rotter 
& Mulry, 1965). Calicchia (1974) used the I-E LOC scale to measure LOC and heroin 
usage. Hall (2001) developed the DRLOC scale to focus specifically on drug abuse 
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among people in treatment programs. Ersche et al. (2012) studied the reliability of the 
DRLOC scale and reported the DRLOC scale to be an effective assessment tool for 
measuring LOC in people with substance use disorders. 
 The DRLOC scale consists of 15 forced choice items that give two statements for 
each item, which forces participants to choose one of the two statements identified as 
either A or  B. Statement A equals one point and statement B equals two points. The 15 
items measure LOC on a continuum from internal to external. After the participant 
complete the DRLOC scale, the interviewer adds the numbers circled by the participant. 
The numbers circled for items 1, 3, 5, 8, 11, 14, and 15 must be reverse coded. After 
recoding, the DRLOC score is computed by taking the mean score of all items. The total 
score is then divided by 15 (the total number of items on the scale) to get the mean score. 
A score that is closer to one represents a more internally controlled locus and a score that 
is closer to two indicates a more externally controlled locus.  
The DRLOC scale was the latest LOC instrument in the field of social science. 
Hall’s (2001) analysis of the DRLOC instrument found α = .81. Hall measured internal 
consistency by applying Cronbach’s alpha and the split-half procedure using the 
Spearman-Brown Prophecy formula. Hall explained the study was large and hindered the 
procedure for test-retest reliability and examined other measures to test convergent 
validity by examining correlations of scores. This included participants’ DRLOC scores 
and Addiction Severity Index scores which were positively correlated (r = .301 p <.00). 
This demonstrated that high scores generated from the Addiction Severity Test (except 
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for the subscale Medical) correlated with a high score on the DRLOC. It should be noted 
that of the seven domains in the Addiction Severity Index scale (medical, employment, 
alcohol and drugs, legal, family and social relationships, and psychiatric) the subscale of 
alcohol and drugs demonstrated the highest correlations with a score of .283.  
Participant Selection 
The purpose of conducting a secondary analysis was to reexamine data on 
individuals who received treatment for their substance use disorder. Specifically, the 
purpose was to examine the main factorial effects of primary drug (narcotic vs. 
stimulant), gender (men vs. women), and their interaction. This was accomplished by re-
examining secondary data generated by the UCLAs Integrated Substance Abuse 
Programs’ Drug Treatment Process and Drug Treatment Counselor Practices and 
Effectiveness study. The sample size in the UCLAs study was 666 participants diagnosed 
with substance use disorders from 19 drug treatment programs. From the UCLAs 
Integrated Substance Abuse Programs’ study, 553 participants agreed to participate in 
Hall’s (2001) Feelings About Drug Use, DRLOC study. From Hall’s study, 402 
participants’ data was used for the Effect Gender and Narcotic or Stimulant Abuse has on 
DRLOC study. Of the 402 participants, 285 reported their drug of choice to be stimulants 
and 117 reported their drug of choice to be narcotics.   
The study consisted of 157 (39.1%) White, 135 (33.6%) were Black/African 
American, 16 (4%) were Asia/Pacific Islander, 5 (1.2%) were Native American, 76 
(18.9%) were Hispanic, 10 (2.5%) were multiracial, and 2 (.5%) were identified as Other. 
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One participant’s data was missing in the system and represented .2% of the 402 
participants. The youngest participant was 19 and the oldest participant was 69 (M = 
35.46, SD = 8.49). The median was 34. Skewness and Kurtosis were both less than 1.0 
and within acceptable range of normal distribution with skewness at .690 and Kurtosis at 
.731.  
Hall’s (2001) report indicated the education level of those who participated in the 
UCLAs study averaged 12.2 years. The sample population for the Effect Gender and 
Narcotic or Stimulant Abuse has on DRLOC (Travis, 2018) study ranged from a 
minimum of 6 years and a maximum of 26 years of education. Years of education had a 
high kurtosis at 5.894 because one case reported 26 years; the next closest was 20. The 
outlier case was recoded to 20, which brought the distribution of the variable within 
acceptable normal range with kurtosis at 1.730 and Skewness at .678. Normal range is 
skewness less than the absolute value of 3 and kurtosis less than the absolute value of 7 
(Kline, 2016). After recoding, the mean was 12.03, standard deviation was 2.25, and the 
median was 12.  
In the case of household income, this variable was coded as range because it is an 
ordinal variable. The mean 3.4091 is not itself valid, but it was used to state that the 
average income was between $15,000 and $24,999. The minimum household income was 
under $10,000 and the maximum was over $200,000. There were 212 cases (53.5%) that 
had a household income under $10,000. 
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Research 
 The research question examined for this study was: To what extent do DRLOC 
scores differ by primary drug (narcotic vs. stimulant), gender (male vs. female), and their 
interaction? 
N01: There is no statistically significant difference (p > .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.  
Na1: There is a statistically significant difference (p < .05) in DRLOC scores 
between participants whose primary drug was a narcotic versus a stimulant.   
N02: There is no statistically significant difference (p > .05) in DRLOC scores 
between males and females.  
Na2: There is a statistically significant difference (p < .05) in DRLOC scores 
between males and females.  
N03: There is no statistically significant interaction effect (p > .05) between 
primary drug and gender on DRLOC scores.  
Na3: There is a statistically significant interaction effect (p < .05) between 
primary drug and gender on DRLOC scores. 
Screening of Demographics as Covariates or Confounds 
The demographic variables, education level, socioeconomic status, age and race 
were screened as potential covariates or confounds. As a result of the screening, 
education level, socioeconomic status, and age did not demonstrate a direct influence or 
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had an effect on DRLOC scores. Therefore, the demographic variables were not included 
as a covariate in the primary analysis.  
Race was recoded into 4 categories because some of the original categories had 
very small numbers of cases: White, African-American, Hispanic, all other. The “All 
Other” category includes Asian/Pacific Islander, Native American, and Multi-racial. 
Levene’s Test of Equality of Error Variances was conducted to test the null hypothesis 
that the error variance of the dependent variable, DRLOC score, was equal across groups. 
Levene’s test was significant, meaning the groups did not have equal variance. However, 
according to Tabachnick and Fidell (2007), if the ratio of the largest group variance to 
that of the smallest group variance is less than 10, than it is okay. In this case the ratio 
was 2.2 (.2482 divided by .1682).  
Analysis of between-subjects demonstrated DRLOC scores do statistically 
significantly differ by race, F(3, 398) = 7.07, p < .001, eta squared = .05 (a medium size 
effect). Hispanics had higher DRLOC scores than both White and African American 
groups. 
To further screen for race and its relationship with primary drug, further analysis 
showed there were more African Americans in the stimulant group (n = 121) than 
statistically expected (n = 95.7), and more Hispanics in the narcotic group (n = 42) than 
statistically expected (n = 22.1), χ2(3, N = 402) = 49.51, p < .001, Cramer’s V = .351. 
There were more female African Americans in the study (n = 94) than statistically 
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expected (n = 80.9), and more male Hispanics in the study (n = 43) than statistically 
expected (n = 30.4), χ2(3, N = 402) = 14.71, p = .002, Cramer’s V = .191.  
Because race was not independent of primary drug or gender, a preliminary 
factorial ANOVA that included race was performed There was not a statistically 
significant effect for race, nor race by primary drug 2-way interaction, nor race by gender 
2-way interaction, nor race by primary drug by gender 3-way interaction. Therefore, race 
was not included in the final inferential analysis to test the hypotheses and answer the 
research questions. As noted in Table 12, Levene’s test is significant, but the ratio of 
largest group variance to smallest group variance was within acceptable range to assume 
homogeneity of error variance (.2352 divided by .1652 = 2.04). 
Factorial ANOVA Results 
A 2 (gender) X 2 (primary drug) factorial ANOVA was conducted. Levene’s test 
was significant, but the ratio of largest group variance to smallest group variance were 
within acceptable range to assume homogeneity of error variance (.2352 divided by .1652 
= 2.04). A between-subject analysis of gender and primary drugs that demonstrated the 
main effect of gender was not significant. Further analysis presented, showed males 
(1.242) and females (1.276) had relatively equal means on DRLOC. The main effect of 
primary drug was significant and the interaction was significant. The narcotic group had 
higher mean (1.358) for DRLOC scores than the stimulant group (1.159). Because the 
interaction was significant, it is invalid to solely rely on the main effects of gender and 
primary drug to understand differences on DRLOC scores. Instead, the focus needs to be 
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on interpreting the interaction. Females in the narcotic group had higher DRLOC scores 
than males, but females in the stimulant group had lower DRLOC scores than males. 
Limitations of the Study 
A limitation identified in the Feelings About Drug Use, DRLOC study derived 
from how the sample population was generated. Participants from the original study were 
populated through a stratified, random selection of patients from 19 different types of 
alcohol and drug treatment programs. Selecting narcotics and stimulants as variables in 
the Effect Gender and Narcotic or Stimulant Abuse has on DRLOC (Travis, 2018) study 
provided more consistency with drug treatment by excluding alcohol and other types of 
drug abuse from the data. However, treatment philosophies and length of treatment still 
presented limitations with consistency within the sample population. 
Other limitations were reflected in reading and writing abilities of the participants 
with education levels ranging from a minimum of 6 years and a maximum of 26 years of 
education. Participant’s education level in the Effect Gender and Narcotics or Stimulant 
Abuse has on DRLOC (Travis, 2018) study averaged 12 years of education.  
Extraneous and confounding variables reflect biopsychosocial triggers in the 
environment, such as the possibility that participants could have been under the influence 
of drugs during the study. The influences of foreign chemicals introduced into the body 
have an effect on behaviors and thought processes (APA, 2013) and could affect the 
response given to questions on the DRLOC instrument.  
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Recommendations 
The focus of the Effect Gender and Narcotics or Stimulant Abuse has on DRLOC 
(Travis, 2018) study was to examine if narcotic or stimulant use among men and women 
affect the DRLOC score, if gender affects the DRLOC score, and if the interactions 
between drug use and gender is significant. It is recommended, from the results of the 
Effect Gender and Narcotics or Stimulant Abuse has on DRLOC (Travis, 2018) study, 
that the DRLOC scale, as a viable instrument for measuring drug-related LOC and 
interactions between drug use and gender, be included as part of a program’s treatment 
protocol.  
Individualize treatment is needed due to gender differences as referenced by the 
scores and specific drugs use reflected in the Effect Gender and Narcotics or Stimulant 
Abuse has on DRLOC (Travis, 2018) study, which demonstrated males in the narcotic 
group had lower DRLOC scores than females, but males in the stimulant group had 
higher DRLOC scores than females. The results of DRLOC scores validates there are 
differences related to gender and primary drug abuse (Shannon et al., 2014) and 
differences in patterns of drug use (Lev-Ran et al., 2013; Samuelsson, 2015).  
Administering the DRLOC scale at admittance into treatment programs, during 
treatment, and at discharge from a program is recommended and could help to measure 
patient’s thought processes and behaviors related to drug activities throughout treatment. 
Administrating the DRLOC scale at the beginning of treatment could also help in 
predicting patient’s willingness to fully engage in treatment (Page and Scalora, 2004), 
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which would allow practitioners to meet patients where they are in their stage of change 
toward recovery. The DRLOC score could also help in determining which evidence-
based treatment fits the individual’s needs and whether or not this intervention worked. 
When treatment programs implement the DRLOC scale as part of the treatment process, 
admittance score that represents External-LOC at the beginning of treatment and shifts to 
Internal-LOC at end of treatment would demonstrate effective interventions, while a 
score from Internal-LOC to External-LOC would demonstrate ineffective interventions 
(Page and Scalora, 2004).  
Further recommendation for a longitudinal study looking at gender, primary drug 
of choice, DRLOC scores obtained throughout treatment, and a specific evidence-based 
intervention to determine if DRLOC scores could measure shifts in behaviors and thought 
progress is needed. For example, administering the DRLOC in specific treatment 
programs, such as methadone maintenance treatment programs, where a sample 
population identifies narcotics as their primary drug of choice, and where each patient is 
being provided methadone as part of the treatment protocol, can serve as the next step for 
examining the effectiveness of the DRLOC scale and its importance in the field of 
addiction and treatment protocol. 
Social Implications 
The Effect Gender and Narcotic or Stimulant Abuse has on DRLOC (Travis, 
2018) study demonstrated the importance of understanding the interaction between 
gender and primary drugs influence on LOC. Social implications for practitioners 
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becoming awareness of this interaction would be helpful with treatment. Social 
implications for treatment programs that administer the DRLOC scale could be beneficial 
for measuring treatment success on the part of the practitioners and patient. Clinicians in 
multiple human service fields and community organizations could benefit by knowing a 
patient’s DRLOC score and then align the score with appropriate evidence-based 
interventions (National Registry of Evidence-based Programs and Practices, 2016).  
Social implication for utilizing the DRLOC score to educate patients about their 
LOC could help patients become aware of their behavior and thought processes. Patients 
could gain a better understanding of how their ongoing drug use is connected to how they 
view their current situation and prior experiences in life and what might be their triggers. 
This knowledge of understanding how drug use and LOC are connected to triggers could 
help patients develop coping skills to recognize and resist triggers for a better quality of 
life.   
Social implications for utilizing a DRLOC instrument for both professionals and 
patients would help to minimize stigma in treatment settings. Practitioners who 
administer a LOC instrument as part of family therapy with each family member could 
see amongst family members a better understanding of a loved one’s addictive behaviors 
and levels of control when each family member is aware of their own LOC and how this 
impacts their interactions with others (Foon, 1986). Being aware of one’s LOC score may 
help family members change their perception and the stigma associated with addictions 
(Foon, 1986) once they understand their love one’s DRLOC score.  
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Social implications may extend to the general public becoming better educated 
about LOC by understanding their personal score could help the public recognize their 
thought processes associated with their decision making and daily responses to events 
and situations. This recognition of how LOC impacts every person’s behavior could 
result in positive shifts in how the public view and treat people with a substance use 
disorder and their DRLOC scores. 
Conclusion 
The results of the Effect Gender and Narcotics or Stimulant Abuse has on the 
DRLOC (Travis, 2018) study, in which a majority of participants were identified as 
stimulant users, coincide with the research conducted in the addiction field. CDADP 
(2013) found Methamphetamine was the most commonly reported primary drug of 
choice in the state, at a rate 13% higher than heroin, and admission rates of 48,345 
patients into treatment for stimulant abuse were higher compared to 38,785 admissions 
for narcotic abuse (SAMHSA, 2016d). These statistics underscore a need to understand 
the importance of structuring treatment with evidence-based interventions by first 
identifying what the individualized needs are for the patient. The Effect Gender and 
Narcotics or Stimulant Abuse has on the DRLOC (Travis, 2018) study demonstrated the 
importance of identifying a patient’s DRLOC score in order to select the best treatment 
intervention for the individual.   
 A more important understanding of gender is needed when treating patients. 
Conflicting ideologies of treating all men and women as equal, compared to addressing 
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gender-specific needs, is a dilemma for some treatment programs because men and 
women are different biopsychosocially (Lev-Ran et al., 2013; Samuelsson, 2015). As 
demonstrated in the Effect of Gender and Narcotics or Stimulant Abuse has on the 
DRLOC (Travis, 2018), DRLOC scores related to gender bared no significant difference. 
However, when examining the interaction between gender and primary drug of choice, 
significant differences occurred. The results support the importance of men and women 
who used narcotics or stimulants benefiting from learning their DRLOC score and being 
provided with evidence-based treatment that addresses their specific drug of choice, 
thought processes, and behaviors.  
 If administered throughout the treatment process, the DRLOC instrument could 
potentially help measure several outcomes: The ability to measure patient’s progress 
throughout treatment through personal awareness and shifts in thought processes and 
behaviors, or the lack thereof. It could provide a reasonable understanding of the minimal 
progress achieved. Most important, the DRLOC instrument could determine the 
appropriate interventions needed that coincide with the patient’s LOC score. 
 In closing, the practice of administering the DRLOC instrument at the beginning 
of treatment, during treatment, and at the end of treatment (Pasareanu et al., 2015) should 
be part of the treatment protocol along with appropriate patient-centered, evidence-based 
interventions that meet the needs of the individual.  
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Appendix A: Permission to use the Drug-Related Locus of Control Dataset  
 
From: yolanda travis [truncated] 
Sent: Monday, March 16, 2015 7:24 AM 
To: [truncated] 
Subject: Doctoral Permission to use the DRLOC 
 
YOLANDA RENE TRAVIS 
[truncated] 
  
March 16, 2015  
  
  
Dr. Elizabeth A. Hall,  
[truncated] 
  
 
Dear Dr. Hall, 
  
My name is Yolanda Rene՜ Travis. I am a doctoral student at Walden University located in Minneapolis, 
Minnesota. I am currently working on my dissertation and I am ready to start my research. I will be 
examining The Relationship Between Impulsivity, Locus of Control, and Addictive Behaviors Among 
People in Methadone Maintenance Treatment Programs.  
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I read your article, Feelings About Drug Use, Drug-Related Locus of Control. I am very excited that you 
have developed an individualized instrument that targets drug use across modalities. My interest is to focus 
on patients diagnosed with Opioid Use Disorder. Your instrument will help my research by measuring 
locus of control over sustained abstinence or ongoing drug use while receiving narcotic therapy at 
Methadone Maintenance Treatment Programs located in Central and Northern California. The DRLOC will 
serve as an effective assessment tool for my research in lieu of having to develop my own instrument to 
measure locus of control in this population.   
  
I would like your permission to use the DRLOC scale in my research to measure internal and external locus 
of control. If I have your permission to use this instrument, please let me know as soon as possible.  
  
My long-term goal is to be a psychologist specializing in addictive behaviors. I look forward to your 
response.  
  
Sincerely, 
  
Yolanda Rene′ Travis  
[truncated] 
 
From: [truncated] 
To: [truncated] 
CC: [truncated] 
Subject: RE: Doctoral Permission to use the DRLOC 
Date: Mon, 16 Mar 2015 13:39:55 -0700 
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Yes, you have my permission to use the DRLOC. It sounds like a fascinating study. Good luck and please 
let me know what you find. 
  
--Betsy 
Elizabeth A. Hall, Ph.D.  
[truncated] 
 
 
UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is only 
intended for the use of the person or entity to which it is addressed, and may contain information that is 
privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential 
manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and 
state penalties. If you are not the intended recipient, please immediately notify us by return email, and 
delete this message from your computer. 
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Appendix B: Drug-Related Locus of Control Scale 
Drug-Related Locus of Control (DRLOC)  
Now, I’m going to ask you about your feelings about drug use. I’m going to read two statements, Statement 
A and Statement B, and ask you to choose the one that best describes how you feel now. 
(CIRCLE ONE NUMBER FOR EACH STATEMENT) 
1. A. I feel so helpless in some situations that I need to get high..........................................................1 
B. Abstinence is just a matter of deciding that I no longer want to use drugs...................................2 
 
2.  A. I have the strength to withstand pressures at work or home.........................................................1 
B. Trouble at work or home drives me to use drugs..........................................................................2 
 
3. A. Without the right breaks you cannot stay clean............................................................................1 
 B. Drug abusers who are not successful in curbing their drug use often have not taken advantage  
 of help that is available.......................................................................................................................2 
 
4.  A. There is no such thing as an irresistible temptation to use drugs..................................................1 
B. Many times there are circumstances that force you to use drugs..................................................2 
 
5. A. I get so upset over small arguments that they cause me to use drugs...........................................1 
B. I can usually handle arguments without using drugs.....................................................................2 
 
6.  A. Successfully kicking substance abuse is a matter of hard work, luck has little or  
 nothing to do with it………………………………………………………...………………………1 
B. Staying clean depends mainly on things going right for you........................................................2 
 
7. A. When I am at a party where others are using, I can avoid taking drugs........................................1 
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B. It is impossible for me to resist drugs if I am at a party where others are using...........................2 
 
8.  A. I feel powerless to prevent myself from using drugs when I am anxious or unhappy..................1 
B. If I really wanted to, I could stop using drugs...............................................................................2 
 
9. A. It is easy for me to have a good time when I am sober.................................................................1 
B. I cannot feel good unless I am high...............................................................................................2 
 
10.  A. I have control over my drug use behaviors...................................................................................1 
B. I feel completely helpless when it comes to resisting drugs..........................................................2 
 
11.  A. Sometimes I cannot understand how people can control their drug use.......................................1 
 B. There is a direct connection between how hard people try and how successful they are  
 in stopping their drug use...................................................................................................................2 
 
12.  A. I can overcome my urge to use drugs............................................................................................1 
B. Once I start to use drugs I can’t stop.............................................................................................2 
 
13.  A. Drugs aren’t necessary in order to solve my problems.................................................................1 
B. I just cannot handle my problems unless I get high first...............................................................2 
 
14.  A. Most of the time I can’t understand why I continue to use drugs.................................................1 
B. In the long run I am responsible for my drug problems................................................................2 
 
15.  A. Taking drugs is my favorite form of entertainment......................................................................1 
B. It wouldn’t bother me if I could never use drugs again............................................ ....................2 
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SCORING: FEELINGS ABOUT DRUG USE 
Drug-Related Locus of Control (DRLOC) 
The Drug-Related Locus of Control scale is a 15-item, forced-choice measure of drug-use 
control expectancies in a variety of drug-use-related situations. The scoring procedures 
below are designed so that clients with a more internal locus of control would produce 
scores nearer to 1, while those with a more external locus of control would produce 
scores nearer to 2. To produce this result, Items 1, 3, 5, 8, 11, 14, and 15 must be reverse 
coded. After recoding, the DRLOC score is computed simply by taking the mean score of 
all the items. 
 
